<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5986900</article-id><article-id pub-id-type="doi">10.3389/fmicb.2018.01108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martinez-Rossi</surname><given-names>Nilce M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/220635/overview"/></contrib><contrib contrib-type="author"><name><surname>Bitencourt</surname><given-names>Tamires A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/564648/overview"/></contrib><contrib contrib-type="author"><name><surname>Peres</surname><given-names>Nalu T. A.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/285290/overview"/></contrib><contrib contrib-type="author"><name><surname>Lang</surname><given-names>Elza A. S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/289093/overview"/></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Eriston V.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/243119/overview"/></contrib><contrib contrib-type="author"><name><surname>Quaresemin</surname><given-names>Natalia R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/539805/overview"/></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>Ma&#x000ed;ra P.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/289534/overview"/></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rossi</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/289402/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Genetics, Ribeir&#x000e3;o Preto Medical School, University of S&#x000e3;o Paulo</institution>, <addr-line>Ribeir&#x000e3;o Preto</addr-line>, <country>Brazil</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Morphology, Federal University of Sergipe</institution>, <addr-line>Aracaju</addr-line>, <country>Brazil</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Edvaldo Antonio Ribeiro Rosa, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Paran&#x000e1;, Brazil</p></fn><fn fn-type="edited-by"><p>Reviewed by: L&#x000ed;via Kmetzsch, Universidade Federal do Rio Grande do Sul, Brazil; Slawomir Milewski, Gda&#x00144;sk University of Technology, Poland</p></fn><corresp id="c001">*Correspondence: Nilce M. Martinez-Rossi, <email>nmmrossi@usp.br</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>1108</elocation-id><history><date date-type="received"><day>15</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>09</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Martinez-Rossi, Bitencourt, Peres, Lang, Gomes, Quaresemin, Martins, Lopes and Rossi.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Martinez-Rossi, Bitencourt, Peres, Lang, Gomes, Quaresemin, Martins, Lopes and Rossi</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Dermatophytes comprise pathogenic fungi that have a high affinity for the keratinized structures present in nails, skin, and hair, causing superficial infections known as dermatophytosis. A reasonable number of antifungal drugs currently exist on the pharmaceutical market to control mycoses; however, their cellular targets are restricted, and fungi may exhibit tolerance or resistance to these agents. For example, the stress caused by antifungal and cytotoxic drugs in sub-inhibitory concentrations promotes compensatory stress responses, with the over-expression of genes involved in cellular detoxification, drug efflux, and signaling pathways being among the various mechanisms that may contribute to drug tolerance. In addition, the ATP-binding cassette transporters in dermatophytes that are responsible for cellular efflux can act synergistically, allowing one to compensate for the absence of the other, revealing the complexity of drug tolerance phenomena. Moreover, mutations in genes coding for target enzymes could lead to substitutions in amino acids involved in the binding of antifungal agents, hindering their performance and leading to treatment failure. The relevance of each one of these mechanisms of resistance to fungal survival is hard to define, mainly because they can act simultaneously in the cell. However, an understanding of the molecular mechanisms involved in the resistance/tolerance processes, the identification of new antifungal targets, as well as the prospective of new antifungal compounds among natural or synthetic products, are expected to bring advances and new insights that facilitate the improvement or development of novel strategies for antifungal therapy.</p></abstract><kwd-group><kwd>dermatophyte</kwd><kwd>stress response</kwd><kwd>drug target</kwd><kwd>drug resistance</kwd><kwd>natural compounds</kwd><kwd>kinase</kwd><kwd>Hsp</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content></funding-source><award-id rid="cn001">2014/03847-7</award-id><award-id rid="cn001">2015/23435-8</award-id><award-id rid="cn001">2016/04274-6</award-id><award-id rid="cn001">2011/08424-9</award-id></award-group><award-group><funding-source id="cn002">Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico<named-content content-type="fundref-id">10.13039/501100008353</named-content></funding-source><award-id rid="cn002">305797/2017-4</award-id><award-id rid="cn002">304989/2017-7</award-id></award-group><award-group><funding-source id="cn003">Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior<named-content content-type="fundref-id">10.13039/501100002322</named-content></funding-source></award-group><award-group><funding-source id="cn004">Funda&#x000e7;&#x000e3;o de Apoio ao Ensino, Pesquisa e Assist&#x000ea;ncia do Hospital das Cl&#x000ed;nicas da Faculdade de Medicina de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo<named-content content-type="fundref-id">10.13039/501100008353</named-content></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="3"/><equation-count count="0"/><ref-count count="181"/><page-count count="18"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>The growing prevalence of human fungal infections, especially in immunocompromised patients, has resulted in these diseases becoming a worldwide public health issue. The immune status of the host determines the outcome of the disease, which may range from limited cutaneous or subcutaneous to invasive, disseminated, and life-threatening infections (<xref rid="B79" ref-type="bibr">Kohler et al., 2017</xref>). The most common fungal infections comprise the dermatomycoses, which constitute fungal infections in the skin that affect both immunocompetent and immunocompromised individuals. Yeasts from the genera <italic>Candida</italic> and <italic>Malassezia</italic>, and molds such as the dermatophytes, serve as the most prevalent etiologic agents of these infections (<xref rid="B64" ref-type="bibr">Havlickova et al., 2008</xref>). Dermatophytes comprise a class of primary pathogenic fungi; i.e., not opportunistic, that requires the cleavage of keratin found in the skin, hair, and nails to acquire nutrients for their survival. The secretion of a broad spectrum of lytic enzymes, such as lipases and proteases, especially keratinases, by the fungal hyphae represents their most studied virulence factor, allowing fungal colonization and maintenance in the host tissue (<xref rid="B109" ref-type="bibr">Monod, 2008</xref>; <xref rid="B125" ref-type="bibr">Peres et al., 2010a</xref>).</p><p>Dermatophytes can be classified as zoophilic or anthropophilic depending on their host prevalence. Whereas zoophilic species are able to cause infections in both animals and humans, the anthropophilic dermatophytes are only able to infect humans. This classification is important as the clinical manifestation is highly influenced by the fungal species along with the immune response they trigger during infection. In humans, zoophilic species are responsible for acute infections, mostly owing to the intense induction of the inflammatory response in the infected tissue. In comparison, anthropophilic species are associated with chronic infections, with a lower cellular infiltration in the skin (<xref rid="B71" ref-type="bibr">Hube et al., 2015</xref>). In the first stages of infection, dermatophytes colonize the skin and stimulate keratinocytes to produce different patterns of cytokines that mediate the inflammatory response and accumulation of leukocytes, mainly neutrophils, in the infected tissue (<xref rid="B126" ref-type="bibr">Peres et al., 2010b</xref>; <xref rid="B71" ref-type="bibr">Hube et al., 2015</xref>; <xref rid="B100" ref-type="bibr">Martinez-Rossi et al., 2017</xref>). Dermatophytes are initially recognized by receptors in the host innate immune cells, such as macrophages, neutrophils, and dendritic cells, which induce the activation of an adaptive response to control infection. <italic>In vitro</italic> and <italic>in vivo</italic> models of infection have shown that anthropophilic species (including <italic>Trichophyton tonsurans</italic>) induce keratinocytes to secrete a limited spectrum of cytokines, mainly IL-8, IL-6, and IL-1&#x003b2;. Alternatively, the zoophilic species <italic>Arthroderma benhamiae</italic> induces a broader spectrum of cytokines, such as IL-8, Il-6, IL-1&#x003b2;, IL-10, IL-2, IL-15, TGF-&#x003b2;, contributing to the higher amount of inflammatory cells in the infection site, which is responsible for fungal clearance, healing, and tissue remodeling (<xref rid="B63" ref-type="bibr">Hau et al., 2015</xref>).</p><p>Induction of the adaptive immunity by innate cells triggers both Th1 and Th17 responses, which are important to control dermatophyte infection, by stimulating cellular-mediated immunity (<xref rid="B63" ref-type="bibr">Hau et al., 2015</xref>; <xref rid="B66" ref-type="bibr">Heinen et al., 2016</xref>). Th17 response increases the infiltration of neutrophils in the infection site, in turn promoting the activation of epithelial cells to produce chemotactic molecules and antimicrobial peptides (<xref rid="B66" ref-type="bibr">Heinen et al., 2016</xref>). Furthermore, the production of antibodies and complement activation is also important to control dermatophytes. Serum analysis of patients with dermatophytosis shows high levels of Th2 cytokines, such as IL-4, IL-5, and IgE (<xref rid="B171" ref-type="bibr">Woodfolk and Platts-Mills, 2001</xref>; <xref rid="B63" ref-type="bibr">Hau et al., 2015</xref>; <xref rid="B61" ref-type="bibr">Gupta C. et al., 2016</xref>). The Th1, Th2, and Th17 immune responses observed in dermatophytosis is believed to reflect the different immunological status of the hosts (<xref rid="B63" ref-type="bibr">Hau et al., 2015</xref>) and may also be due to the infecting species. Moreover, genetic factors play a further role in the susceptibility to invasive dermatophytosis (<xref rid="B53" ref-type="bibr">Garcia-Romero and Arenas, 2015</xref>). In particular, mutations in the <italic>card9</italic> gene render a more invasive lesion in patients with dermatophytosis, together with a concomitant lower level of IL17 (<xref rid="B88" ref-type="bibr">Lanternier et al., 2013</xref>).</p><p>Despite the availability of several antifungal drugs for clinical use, these act on a limited number of cellular targets. Commercially available drugs act on the plasma membrane, cell wall, nucleic acids, and the process of cell division. In particular, three classes of antifungal drugs interfere with the plasma membrane. Azoles and triazoles inhibit the enzyme sterol 14 &#x003b1;-demethylase, and the allylamines inhibit squalene epoxidase, both leading to inhibition of ergosterol biosynthesis. Allylamines also lead to the accumulation of lanosterol, a toxic intermediary compound of the ergosterol biosynthesis pathway. Polyenes bind to ergosterol, thus reducing plasma membrane integrity. Echinocandins comprise a class of cell wall interfering agents that inhibit &#x003b2;-glucan synthase. The pyrimidine analog 5-fluorocytosine inhibits DNA and RNA synthesis, leading to cell division and protein synthesis defects. Griseofulvin (GRS) interferes with microtubule formation, impairing fungal growth and cell division. Finally, ciclopirox oleamine functions as a protein synthesis inhibitor, which is often used against dermatophytes (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>).</p><p>The overlapping mechanisms of action of the commonly used drugs may contribute to the multidrug resistance (MDR) phenotypes observed for several pathogenic fungi. Moreover, is common for patients to neglect and abandon treatment, owing to its requirement for long term use and the associated side effects (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>; <xref rid="B125" ref-type="bibr">Peres et al., 2010a</xref>). In turn, clinical and/or microbiological resistance may result in treatment failure. Specifically, clinical resistance is defined as the failure of infection clearance even with the administration of drugs that display <italic>in vitro</italic> activity, whereas microbial resistance relies on different molecular mechanisms used by the fungus to overcome the inhibitory effects of the antifungal drugs (<xref rid="B75" ref-type="bibr">Kanafani and Perfect, 2008</xref>). Several such mechanisms may be triggered by the fungus, which can act alone or in combination. These mechanisms involve the overexpression of efflux pumps or detoxification enzymes, along with target and drug modification (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>; <xref rid="B32" ref-type="bibr">Cowen et al., 2015</xref>; <xref rid="B131" ref-type="bibr">Pianalto and Alspaugh, 2016</xref>).</p><p>In this review, we provide a special emphasis on the mechanisms of stress response and antifungal resistance in dermatophytes, and the prospective for the use of novel drugs to treat cutaneous fungal infections.</p></sec><sec><title>Natural and Synthetic Compounds with Antifungal Activity</title><p>Fungal infections are increasing owing to various factors, whereas the current antifungal arsenal shows considerable drawbacks mainly related to their side effects and the emergence of drug resistance (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>). Therefore, it is imperative to develop new agents with effective and specific modes of action.</p><p>Currently, synthetic drugs acting on novel cellular targets are under investigation, or in preclinical or clinical trials. These drugs include inhibitors of metabolic pathways, such as the glyoxylate cycle, pyrimidine biosynthesis, cytochrome P450 pathway, iron metabolism, acetate metabolism, and heme biosynthesis, along with signal transduction pathways, such as mitogen-activated protein (MAP) kinase and calcium signaling pathways, as well as transcription factor and DNA-binding and histone deacetylase inhibitors, with the latter representing epigenetic therapy (<xref rid="B104" ref-type="bibr">McCarthy et al., 2017</xref>) (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Novel antifungal drugs currently under evaluation, preclinical or clinical trial.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Target</th><th valign="top" align="left" rowspan="1" colspan="1">Drugs (phase of development)</th><th valign="top" align="left" rowspan="1" colspan="1">Proposed mechanism of action</th><th valign="top" align="left" rowspan="1" colspan="1">Fungi tested</th><th valign="top" align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell membrane</td><td valign="top" align="left" rowspan="1" colspan="1">BHBM D0 (preclinical)</td><td valign="top" align="left" rowspan="1" colspan="1">Interferes with fungal vesicles, and synthesis of sphingolipids</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cryptococcus</italic> spp. <italic>Candida</italic> spp. <italic>Aspergillus fumigatus Rhizopus oryzae Blastomyces dermatitidis Histoplasma capsulatum Coccidioides Paecilomyces variotii Pneumocystis jirovecii</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B110" ref-type="bibr">Mor et al., 2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">VT-1129 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of Cyp51 (lanosterol 14-&#x003b1;-demethylase)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cryptococcus Candida</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B95" ref-type="bibr">Lockhart et al., 2016</xref>; <xref rid="B145" ref-type="bibr">Schell et al., 2017b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">VT-1598 (investigational)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of Cyp51 (lanosterol 14-&#x003b1;-demethylase)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus</italic> sp. <italic>Cryptococcus</italic> sp. <italic>Rhizopus</italic> sp. <italic>Coccidioides</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B169" ref-type="bibr">Wiederhold et al., 2018a</xref>,<xref rid="B170" ref-type="bibr">b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">VT-1161 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of Cyp51 (lanosterol 14-&#x003b1;-demethylase)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Trichophyton mentagrophytes Trichophyton rubrum Epidermophyton floccosum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B167" ref-type="bibr">Warrilow et al., 2014</xref>; <xref rid="B54" ref-type="bibr">Garvey et al., 2015</xref>; <xref rid="B145" ref-type="bibr">Schell et al., 2017b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nucleic acid</td><td valign="top" align="left" rowspan="1" colspan="1">F901318 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of dihydroorotate dehydrogenase (pyrimidine biosynthesis pathway)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Aspergillus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B119" ref-type="bibr">Oliver et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">MGCD290 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the Hos2 histone deacetylase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus</italic> sp. <italic>Cryptococcus</italic> sp. <italic>Rhodotorula</italic> sp. <italic>Fusarium</italic> sp. <italic>Trichosporon</italic> sp. <italic>Scedosporium</italic> sp. <italic>Zygomycetes</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B129" ref-type="bibr">Pfaller et al., 2009</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitochondria</td><td valign="top" align="left" rowspan="1" colspan="1">T-2307<sup>3</sup> (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Disruption of the fungal mitochondrial membrane potential</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Cryptococcus</italic> sp. <italic>Aspergillus</italic> sp. <italic>Fusarium solani Malassezia furfur Mucor racemosus</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B107" ref-type="bibr">Mitsuyama et al., 2008</xref>; <xref rid="B115" ref-type="bibr">Nishikawa et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Ilicicolin H (investigational)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the cytochrome bc1 reductase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus</italic> sp. <italic>C. neoformans</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B153" ref-type="bibr">Singh et al., 2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heme biosynthesis</td><td valign="top" align="left" rowspan="1" colspan="1">Sampangine (investigational)</td><td valign="top" align="left" rowspan="1" colspan="1">Interferes with heme metabolism</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>C. neoformans C. albicans C. glabrata C. krusei A. fumigatus</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B1" ref-type="bibr">Agarwal et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Hemofungin (investigational)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of ferrochelatase, an enzyme from the heme biosynthesis pathway</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Aspergillus</italic> sp. <italic>Candida</italic> sp. <italic>Fusarium</italic> sp. <italic>Rhizopus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B10" ref-type="bibr">Ben Yaakov et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Metabolism</td><td valign="top" align="left" rowspan="1" colspan="1">AR-12 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of acetyl coenzyme A (acetyl-CoA) synthetase (acetate metabolism)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>C. neoformans Candida</italic> sp. <italic>Fusarium</italic> sp. <italic>Mucor</italic> sp. <italic>Blastomyces</italic> sp. <italic>Histoplasma</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B81" ref-type="bibr">Koselny et al., 2016</xref>; <xref rid="B83" ref-type="bibr">Kushwaha et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Coccidioides</italic> sp. <italic>Trichophyton rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Mohangamides (investigational)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the isocitrate lyase (glyoxylate pathway)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida albicans</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B7" ref-type="bibr">Bae et al., 2015</xref>; <xref rid="B104" ref-type="bibr">McCarthy et al., 2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">ASP2037</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown (iron metabolism)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Aspergillus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B3" ref-type="bibr">Arendrup et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell wall</td><td valign="top" align="left" rowspan="1" colspan="1">Biafungin (CD101) (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of glucan synthase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B130" ref-type="bibr">Pfaller et al., 2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Scy-078 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of glucan synthase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B144" ref-type="bibr">Schell et al., 2017a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Nikkomycin Z (completed clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of chitin synthase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Blastomyces dermatitidis Coccidioides</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B24" ref-type="bibr">Clemons and Stevens, 1997</xref>; <xref rid="B151" ref-type="bibr">Shubitz et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GPI anchor biosynthesis</td><td valign="top" align="left" rowspan="1" colspan="1">E-1210/APX001 (clinical trial)</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition of inositol acyltransferase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> sp. <italic>Aspergillus fumigatus Scedosporium prolificans Fusarium solani Paecilomyces lilacinus</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B108" ref-type="bibr">Miyazaki et al., 2011</xref></td></tr></tbody></table><table-wrap-foot><attrib><italic>Drugs: <italic>N</italic>&#x02019;-(3-bromo-4-hydroxybenzylidene)-2-methylbenzohydrazide, BHBM; 3-bromo-N0-(3-bromo-4-hydroxybenzylidene) benzohydrazide, D0; 4-{3-[1-(3-{4-[amino(imino)methyl]phenoxy}propyl)piperidin-4-yl]propoxy}benzamidine, T-2307. Clinical trials were accessed at the website <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov">https://clinicaltrials.gov</ext-link>.</italic></attrib></table-wrap-foot></table-wrap><p>The majority of these molecules had been evaluated for their efficacy against fungi responsible for systemic and life-threatening diseases, such as <italic>Candida</italic> sp., <italic>Cryptococcus</italic> sp., and <italic>Aspergillus fumigatus</italic> (<xref rid="B131" ref-type="bibr">Pianalto and Alspaugh, 2016</xref>; <xref rid="B104" ref-type="bibr">McCarthy et al., 2017</xref>). However, few studies have evaluated the effect of these drugs in dermatophytes. In particular, VT-1161 is currently under phase I clinical trial for onychomycosis NCT02267356 (<xref rid="B54" ref-type="bibr">Garvey et al., 2015</xref>; <xref rid="B144" ref-type="bibr">Schell et al., 2017a</xref>). This drug inhibits the fungal cytochrome P-450 enzyme lanosterol 14-&#x003b1;-demethylase (Cyp51), being effective against several fungi including the dermatophytes <italic>Trichophyton rubrum, Trichophyton mentagrophytes</italic>, and <italic>Epidermophyton floccosum</italic> (<xref rid="B54" ref-type="bibr">Garvey et al., 2015</xref>). Moreover, VT-1161 has shown efficacy in a guinea pig infection model of dermatophytosis caused by <italic>T. mentagrophytes</italic> (<xref rid="B54" ref-type="bibr">Garvey et al., 2015</xref>). AR-12 constitutes an anti-tumor drug that inhibits acetyl coenzyme A (acetyl-CoA) synthetase, which is currently in clinical trial for lymphoma and solid tumors (NCT00978523). This drug also exhibits antifungal activity against several life-threatening fungi (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>) as well as the dermatophyte <italic>T. rubrum</italic> (<xref rid="B81" ref-type="bibr">Koselny et al., 2016</xref>; <xref rid="B83" ref-type="bibr">Kushwaha et al., 2017</xref>). In addition, AR-12 is able to reach the human nail plate and is thus considered a promising drug to treat onychomycosis (<xref rid="B83" ref-type="bibr">Kushwaha et al., 2017</xref>).</p><p>Moreover, plant kingdom diversity is widely unexplored and can serve as a source for almost limitless compounds. In particular, many plant secondary metabolites have drawn attention as being endowed with antifungal properties. In addition, these natural sources lead to novel structural entities, which can be used directly or function as a precursor for the development of better and more effective molecules (<xref rid="B4" ref-type="bibr">Arif et al., 2009</xref>; <xref rid="B114" ref-type="bibr">Negri et al., 2014</xref>). The identification of promising molecules with antifungal properties can be streamlined through the screening of crude plant extract to aid the discovery process as the first step of investigation, followed by assays geared toward the identification of molecules responsible for the antifungal activity (<xref rid="B93" ref-type="bibr">Liu et al., 2009</xref>; <xref rid="B105" ref-type="bibr">Medeiros et al., 2011</xref>; <xref rid="B114" ref-type="bibr">Negri et al., 2014</xref>). Notably, this process has provided some evidence of the biological properties of plant extracts and their phytochemical compounds against dermatophytes (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Antifungal compounds derived from plants extracts showing activity against dermatophytes.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Plant</th><th valign="top" align="left" rowspan="1" colspan="1">Phytochemical</th><th valign="top" align="left" rowspan="1" colspan="1">Dermatophyte</th><th valign="top" align="left" rowspan="1" colspan="1">MIC values</th><th valign="top" align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Thymbra capitata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">EO, carvacrol (&#x0003e;65%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 dermatophyte strains</td><td valign="top" align="left" rowspan="1" colspan="1">0.08&#x02013;0.32 &#x003bc;L/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B139" ref-type="bibr">Salgueiro et al., 2004</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Juniperus</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">EO, &#x003b1;-pinene (&#x0003e;48%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. floccosum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">0.08&#x02013;2.5 &#x003bc;L/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">Cavaleiro et al., 2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Microsporum</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lippia gracilis</italic> LGRA-106</td><td valign="top" align="left" rowspan="1" colspan="1">EO, thymol (&#x0003e;61%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">23.44&#x02013;46.87 &#x003bc;L/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B35" ref-type="bibr">de Melo et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lippia gracilis</italic> LGRA-109</td><td valign="top" align="left" rowspan="1" colspan="1">EO, carvacrol (&#x0003e;54%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">46.87&#x02013;93.75 &#x003bc;L/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B35" ref-type="bibr">de Melo et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Thymus vulgaris</italic></td><td valign="top" align="left" rowspan="1" colspan="1">EO thymol (&#x0003e;48%)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">NT<sup>&#x02217;</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B156" ref-type="bibr">Sokovic et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Vernonanthura tweedieana</italic></td><td valign="top" align="left" rowspan="1" colspan="1">sesquiterpene (6-cinnamoyloxy-1-hydroxyeudesm-4-en-3-one)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. mentagrophytes</italic><break/><italic>M. gypseum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">4&#x02013;8 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B132" ref-type="bibr">Portillo et al., 2005</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Zuccagnia punctata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Chalcones</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">8&#x02013;16 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B158" ref-type="bibr">Svetaz et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>M. gypseum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Glaucium oxylobum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Alkaloids</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">300 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B112" ref-type="bibr">Morteza-Semnani et al., 2003</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Microsporum</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. floccosum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tabernaemontana catharinensis</italic></td><td valign="top" align="left" rowspan="1" colspan="1">MMV alkaloid</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">0.16 mg/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B105" ref-type="bibr">Medeiros et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Baccharis darwinii</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Diversinin (coumarin)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">15.6 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B82" ref-type="bibr">Kurdelas et al., 2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>M. gypseum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Baccharis darwinii</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anisocoumarin H</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">62.5 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B82" ref-type="bibr">Kurdelas et al., 2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>M. gypseum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lavandula viridis L&#x02019;He&#x02032;r</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Monoterpenes</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">0.32&#x02013;0.64 &#x003bc;L/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B181" ref-type="bibr">Zuzarte et al., 2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Microsporum</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. floccosum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Piper ecuadorense</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Pinocembrin</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">125 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B134" ref-type="bibr">Ramirez et al., 2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Dorstenia barteri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Isobavachalcone</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">1.2 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B103" ref-type="bibr">Mbaveng et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>M. audorium</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Dorstenia barteri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Amentoflavone</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. rubrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">39.1 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B103" ref-type="bibr">Mbaveng et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Terminalia chebula</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Apigenin</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T. mentagrophytes</italic></td><td valign="top" align="left" rowspan="1" colspan="1">NT<sup>&#x02217;</sup></td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B152" ref-type="bibr">Singh et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Piper solmsianum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Orientin</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Microsporum</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02264;9 &#x003bc;g/mL)</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B33" ref-type="bibr">De Campos et al., 2005</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>Trichophyton</italic> sp.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>E. floccosum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><attrib><italic><sup>&#x02217;</sup>NT, MIC values non-tested, but antifungal activity evaluated through <italic>in vivo</italic> assays.</italic></attrib></table-wrap-foot></table-wrap><p>In particular, plant metabolites possess diverse anti-infective activity. Coumarins exhibit immunoregulatory effects toward macrophages, whereas quinones bind with adhesins and cell wall polypeptides, impairing their function. Saponines are grouped into three main categories: triterpenoid, steroid, or steroidal glycoalkaloid, and act by disrupting sterol-containing membranes, leading to a breakdown and loss of cellular integrity (<xref rid="B78" ref-type="bibr">Keukens et al., 1995</xref>; <xref rid="B4" ref-type="bibr">Arif et al., 2009</xref>). Moreover, phenolic compounds exert activity on different biological pathways and cellular targets, as previously reported against <italic>Candida</italic> sp. For example, cinnamic acid has an immunoregulatory effect on the activation of monocytes (<xref rid="B27" ref-type="bibr">Conti et al., 2013</xref>), curcumin and isoquercitrin cause cellular membrane damage (<xref rid="B91" ref-type="bibr">Lee and Lee, 2014</xref>; <xref rid="B177" ref-type="bibr">Yun et al., 2015</xref>), licochalcone A leads to the impairment of hyphae development (<xref rid="B161" ref-type="bibr">Teodoro et al., 2015</xref>), and caffeic acid inhibits isocitrate lyase (<xref rid="B23" ref-type="bibr">Cheah et al., 2014</xref>). In addition, the blocking of drug transporters pumps by curcumin (<xref rid="B149" ref-type="bibr">Sharma et al., 2009</xref>), thymol, carvacrol, and baicalein has also been reported (<xref rid="B161" ref-type="bibr">Teodoro et al., 2015</xref>).</p><p>The phytochemical effects on different cellular targets have also prompted investigation of the actions of these compounds toward dermatophytes. Studies have demonstrated fungitoxicity of the monoterpene linalool toward <italic>T. rubrum</italic> (<xref rid="B36" ref-type="bibr">de Oliveira Lima et al., 2017</xref>), as well as that of thymol and carvacrol; moreover, the essential oils from two <italic>Lippia gracilis</italic> genotypes (LGRA-106 and LGRA-109) presented antidermatophytic activity similar to that of FLC (<xref rid="B35" ref-type="bibr">de Melo et al., 2013</xref>). In addition, the MMV alkaloid (12-methoxy-4-methylvoachalotine) showed antifungal activity against <italic>T. rubrum</italic> (<xref rid="B105" ref-type="bibr">Medeiros et al., 2011</xref>). Finally, the chalcones, which comprise open-chain flavonoids, exhibit antifungal activity toward dermatophytes through the inhibition of cell wall biosynthesis (<xref rid="B13" ref-type="bibr">Boeck et al., 2005</xref>), and the blockage of FAS (<xref rid="B12" ref-type="bibr">Bitencourt et al., 2013</xref>).</p><p>Other studies have also attempted to assess the detailed modes of action of biomolecules against <italic>T. rubrum</italic>. For example, the glycoalkaloid &#x003b1; solanine showed antifungal activity toward <italic>T. rubrum</italic>, causing the down-regulation of the <italic>erg1, erg11, mep4</italic>, and <italic>mdr2</italic> genes, which were evaluated in a co-culture of <italic>T. rubrum</italic> with a keratinocyte cell line (<xref rid="B80" ref-type="bibr">Komoto et al., 2015</xref>). Caffeic acid also demonstrated antifungal activity against <italic>T. rubrum</italic>, with its mode of action appearing to be related to a decrease in ergosterol content, impairing the cellular membrane, along with a moderate inhibition of isocitrate lyase activity (<xref rid="B19" ref-type="bibr">Cantelli et al., 2017</xref>). Similarly, the flavonoids quercetin and luteolin showed activity against <italic>T. rubrum</italic> as well. Quercetin was assayed more comprehensively; the data hinted that its mode of action was related to ergosterol reduction, membrane damage, and the inhibition of FAS activity (<xref rid="B12" ref-type="bibr">Bitencourt et al., 2013</xref>). In this context, a <italic>trans</italic>-chalcone compound also simultaneously inhibited the synthesis of fatty acid and ergosterol, and showed marked inhibitory activity against strains of <italic>T. rubrum</italic> (<xref rid="B12" ref-type="bibr">Bitencourt et al., 2013</xref>; <xref rid="B80" ref-type="bibr">Komoto et al., 2015</xref>). Moreover, licochalcone A presented marked antifungal activity toward <italic>T. rubrum</italic>, causing the down-regulation of genes encoding putative virulence factors such as isocitrate lyase, citrate synthase, and malate synthase as well as of genes involved in cell wall synthesis and ergosterol biosynthesis. In addition, this compound impaired hyphal development during the interaction of <italic>T. rubrum</italic> with a keratinocyte cell line, and markedly inhibited the isocitrate lyase activity (<xref rid="B19" ref-type="bibr">Cantelli et al., 2017</xref>). Finally, chalcone treatment led to a down-regulation of a gene coding for a drug efflux pump during the co-culture of <italic>T. rubrum</italic> conidia with a keratinocyte cell line (<xref rid="B80" ref-type="bibr">Komoto et al., 2015</xref>).</p><p>Chalcones constitute widespread natural molecules that are a subject of increasing interest owing to their numerous pharmacological activities (<xref rid="B117" ref-type="bibr">Nowakowska, 2007</xref>). These compounds are considered interesting and promising molecules, and their simple chemical structures allow their synthesis in a secure, inexpensive, and straightforward manner (<xref rid="B113" ref-type="bibr">Narender and Reddy, 2007</xref>). They exhibit antifungal activity against both different and specific fungal targets, and also play a role as MDR modulators. For example, the inhibition of an MDR efflux pump (P-glycoprotein &#x02013; P-gp) by chalcones was previously assessed through testing distinct methoxy-chalcones B-ring derivatives in a human <italic>mdr1</italic> gene transfected into a mouse lymphoma cell line, which showed a high binding affinity to P-gp, exceeding that of a known MDR blocking agent (<xref rid="B72" ref-type="bibr">Ivanova et al., 2008</xref>). Moreover, the use of chalcone analogs also promoted the sensitization of a fluconazole-resistant <italic>C. albicans</italic> strain mediated by the inhibition of efflux pumps (<xref rid="B84" ref-type="bibr">Lacka et al., 2015</xref>; <xref rid="B166" ref-type="bibr">Wang et al., 2016</xref>).</p><p>Taking into account the features of natural compounds together with the increasing need for new drugs, which has been mainly forestalled owing to the challenges afforded by similarities shared between mammalian and fungal cells, these molecules, and their derivatives appear as promising alternative sources for the development of new antifungal agents. Additionally, their combinatory effects with synthetic and the commercial drugs may represent new strategies for antifungal therapies.</p></sec><sec><title>Mechanisms of Resistance</title><sec><title>Drug Exposure, Stress Responses, and Adaptation</title><p>Fungi must sense and respond appropriately to environmental changes to survive cellular stresses, such as those caused by drug exposure. They have evolved diverse mechanisms for adaptation with complex circuitries involving cellular responses, including the interplay among signaling molecules, stress responses, and drug resistance (<xref rid="B29" ref-type="bibr">Cowen, 2008</xref>). Following drug exposure, cell wall instability, changes in osmolarity, and production of reactive oxygen species are among the stimuli that can activate signaling pathways, such as the cell wall integrity pathway, calcineurin signaling, and high osmolarity glycerol (HOG) pathway to counteract the effects of drug-induced stress (<xref rid="B65" ref-type="bibr">Hayes et al., 2014</xref>). Critical signaling pathways involved in the tolerance to antifungal agents are modulated by stress responses governed by the molecular chaperone Hsp90, a global cellular regulator that controls the stability and activation of key regulators of stress responses, such as calcineurin and the MAP kinase in the Pkc1 cell wall integrity pathway, Mkc1 (<xref rid="B135" ref-type="bibr">Robbins et al., 2017</xref>).</p><p>Among pathogenic fungi, most of the known molecular mechanisms underlying drug stress response, drug tolerance, or resistance were initially elucidated in <italic>Candida</italic> sp., <italic>Aspergillus</italic> sp., and <italic>Cryptococcus</italic> sp., and they are still poorly understood in dermatophytes. In particular, it is still challenging to utilize gene targeting to study gene function in most species of this group of fungi; thus, transcriptomics have been applied to better understand the molecular mechanisms involved in drug-stress responses and adaptation. For example, <italic>T. interdigitale</italic> and <italic>T. rubrum</italic> respond to sub-lethal doses of several antifungal compounds by modulating the expression of genes related to various processes, such as protein transport, drug efflux, lipid metabolism, signal transduction, translation, post-translational modifications, and oxidative stress, depending on the drug and time of exposure (<xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>; <xref rid="B175" ref-type="bibr">Yu et al., 2007a</xref>; <xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref>, <xref rid="B179" ref-type="bibr">2009</xref>; <xref rid="B126" ref-type="bibr">Peres et al., 2010b</xref>; <xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>; <xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). Specifically, a gene encoding a transposable element was shown to be up-regulated in <italic>T. interdigitale</italic> after exposure to several drugs (<xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>; <xref rid="B126" ref-type="bibr">Peres et al., 2010b</xref>). In turn, transposable elements can influence gene expression; in <italic>Schizosaccharomyces pombe</italic>, the preferential integration of the retrotransposon Tf1 into promoters of stress response genes has been reported, thereby enhancing their expression (<xref rid="B47" ref-type="bibr">Feng et al., 2013</xref>). However, the regulatory mechanisms involved in stress responses are complex. Recently, a refined use of pre-mRNA processing events has been reported in <italic>T. rubrum</italic> in response to undecanoic acid (UDA), regulating the expression of genes encoding phosphoglucomutase, which is involved in gluconeogenesis and in cell wall biosynthesis, along with inosine monophosphate dehydrogenase, a key enzyme supplying guanine nucleotides to cells (<xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). These mechanisms, along with others, collectively help the cells to counteract the toxicity of drugs and cope with stress.</p><p>It has been reported that the repeated exposure of <italic>T. rubrum</italic> to sub-lethal doses of antifungal drugs <italic>in vitro</italic> can lead to the selection of strains able to survive higher minimal inhibitory concentrations (MICs) following drug pressure. However, in the absence of such pressure, a fraction of the strains regained susceptibility (<xref rid="B55" ref-type="bibr">Ghelardi et al., 2014</xref>). The strains that survive higher MICs can be classified either as tolerant, being able to survive transient exposure, or resistant, having acquired mutations that confer the stable ability to survive higher MICs (<xref rid="B37" ref-type="bibr">Delarze and Sanglard, 2015</xref>). In particular, in <italic>Candida</italic> sp. and <italic>Aspergillus</italic> sp., Hsp90 promotes drug tolerance by stabilizing key regulators of cellular stress responses (<xref rid="B135" ref-type="bibr">Robbins et al., 2017</xref>), thus controlling the downstream signaling pathways.</p><p>Therefore, fungal survival in inhospitable environments, as in the presence of antifungal agents, relies on the stress responses and involves a global modulation of gene expression, resulting in the synthesis of specific proteins that are fundamental to counteract stress. The relevance of these genes in the survival of fungi suggests that they may be considered as potential therapeutic targets. Here, we focus mainly on the drug stress response related to drug efflux, drug detoxification, and the modulation of kinase and heat shock (<italic>hsp)</italic> genes.</p></sec><sec><title>Drug Efflux</title><p>Efflux cell membrane transporters are proteins capable of binding to different compounds including antifungal drugs, and subsequently extruding them from the cell. The expression of these molecular pumps represents one of the main reasons for treatment failure, acting as a protective mechanism against the cytotoxic effects of the drug by reducing the accumulation of harmful compounds (<xref rid="B133" ref-type="bibr">Putman et al., 2000</xref>; <xref rid="B21" ref-type="bibr">Cervelatti et al., 2006</xref>; <xref rid="B41" ref-type="bibr">El-Awady et al., 2016</xref>). The efflux cell activity leads to a gradual and non-specific increase in drug resistance by diminishing the expected effect <italic>in vivo</italic>.</p><p>In turn, enhanced drug export represents a critical strategy among the mechanisms used by fungi to gain resistance toward antifungal therapy (<xref rid="B150" ref-type="bibr">Sharma and Prasad, 2011</xref>). The modification of efflux transporters in fungal resistance contributes to the pathogenicity, favoring the occurrence of cases of dermatophytosis by providing a colonization advantage to the fungus (<xref rid="B26" ref-type="bibr">Coleman and Mylonakis, 2009</xref>). In particular, MDR results to a large degree from the overexpression of genes belonging to the ATP-binding cassette superfamily (ABC), which is evolutionarily conserved in both prokaryotes and eukaryotes. These proteins contain two distinct regions: a highly conserved nucleotide-binding domain and a quite variable transmembrane domain. Through the binding and hydrolization of ATP, ABC transporters actively move a wide variety of structurally and chemically unrelated compounds across membranes, thereby reducing drug accumulation even in cancer cells (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>; <xref rid="B69" ref-type="bibr">Housman et al., 2014</xref>; <xref rid="B172" ref-type="bibr">Xiong et al., 2015</xref>). This superfamily encompasses three well-studied families involved in the efflux of toxic compounds: MDR, MDR-associated protein (MRP), and the pleiotropic drug resistance (PDR) families (<xref rid="B26" ref-type="bibr">Coleman and Mylonakis, 2009</xref>).</p><p>The availability of the genome sequence of different dermatophytes has revealed a homogeneous group of these transporters, which exhibits very low genetic diversity with only a few exclusive genes in each analyzed species (<xref rid="B17" ref-type="bibr">Burmester et al., 2011</xref>; <xref rid="B98" ref-type="bibr">Martinez et al., 2012</xref>). The analysis of seven of these dermatophyte genomes identified a large number of encoded ABC transporter domains with many of the associated genes having counterparts in all studied species, suggesting that ABC transporter genes act equivalently, despite the phenotypic and adaptive uniqueness of each species (<xref rid="B51" ref-type="bibr">Gadzalski et al., 2016</xref>).</p><p>Evidence implicating drug efflux as a mechanism of resistance has been extensively evaluated in the <italic>T. interdigitale</italic> H6 strain (previously identified as <italic>T. rubrum</italic>). Initially, the occurrence of a drug efflux phenomenon was hypothesized consequent to an observed resistance to both GRS and tioconazole <italic>in vitro</italic> (<xref rid="B44" ref-type="bibr">Fachin et al., 1996</xref>). Subsequently, <italic>mdr1</italic> and <italic>mdr2</italic> genes were identified, which presented an increased level of transcription after exposure to different classes of antifungal agents (<xref rid="B21" ref-type="bibr">Cervelatti et al., 2006</xref>; <xref rid="B43" ref-type="bibr">Fachin et al., 2006</xref>; <xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>). The disruption of the <italic>mdr2</italic> gene rendered a mutant more sensitive to terbinafine (TRB) but not to other tested drugs, precluding the suggestion of a modulatory role of the <italic>mdr2</italic> gene in drug susceptibility (<xref rid="B43" ref-type="bibr">Fachin et al., 2006</xref>). Gene expression analysis later demonstrated that the <italic>mdr4</italic> gene somehow depends on the MDR2 transporter when challenged with antifungal agents, suggesting the existence of network interaction with regard to MDR activity as well as the interdependence of different ABC transporters in drug efflux (<xref rid="B174" ref-type="bibr">Yibmantasiri et al., 2014</xref>; <xref rid="B102" ref-type="bibr">Martins et al., 2016</xref>).</p><p>Different ABC transporters with overlapping substrate profiles may present broad ranges of substrate affinity and capacity of transport, and may respond differently to cellular drug-concentrations, thereby determining the actual fate of the substrates (<xref rid="B56" ref-type="bibr">Glavinas et al., 2004</xref>). For example, the transcriptional profiling of the <italic>pdr1, mdr2</italic>, and <italic>mdr4</italic> genes of four species of <italic>Trichophyton</italic>: <italic>T. equinum, T. interdigitale, T. rubrum</italic>, and <italic>T. tonsurans</italic>, did not reflect the intrinsic phylogenetic relationship among these fungi, nor was a functional correlation revealed between species and the efflux modulation under the tested conditions. However, the evaluated genes appear to work synergistically, leading to the understanding that one <italic>mdr</italic> gene may be compensated by others as related to extrusion activity (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>; <xref rid="B51" ref-type="bibr">Gadzalski et al., 2016</xref>; <xref rid="B102" ref-type="bibr">Martins et al., 2016</xref>).</p><p>Owing to the relevant contribution of drug efflux resistance mechanisms to the pathogenesis of dermatophytes, the use of inhibitors or modulators of ABC transporters to block and reverse MDR response represents a potential alternative method to thwart multidrug transporter activity, thus preventing the occurrence of drug efflux (<xref rid="B56" ref-type="bibr">Glavinas et al., 2004</xref>; <xref rid="B150" ref-type="bibr">Sharma and Prasad, 2011</xref>; <xref rid="B67" ref-type="bibr">Holmes et al., 2016</xref>). An assortment of such compounds present MDR modulatory properties by synergistically enhancing fungicidal activity, although these still require a definitive demonstration of clinical efficacy. The identified inhibitors include isonitrile, enniatins, milbemycins, ibuprofen, and the calcineurin inhibitor FK506. These compounds present effective efflux blocking activity in a terbinafine-resistant strain of the dermatophyte <italic>Microsporum canis</italic> as well as in multiple types of eukaryotic cells including malignant cells (<xref rid="B77" ref-type="bibr">Kawahara et al., 2015</xref>; <xref rid="B67" ref-type="bibr">Holmes et al., 2016</xref>; <xref rid="B76" ref-type="bibr">Kano et al., 2018</xref>). However, it is relevant to consider that cells can heterogeneously express ABC transporters, varying the responses between fungal species, patients, as well as within tumors, potentially impairing their activity (<xref rid="B67" ref-type="bibr">Holmes et al., 2016</xref>; <xref rid="B102" ref-type="bibr">Martins et al., 2016</xref>). Moreover, the many similarities between fungal and human cells represent a challenge for host treatments in regard to the currently limited antifungal choices (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>). As multidrug transporter genes are also relatively conserved from microorganisms to humans, an ideal MDR- interfering drug must therefore be capable of chemosensitizing cells to existing effective antifungal agents while also shielding human orthologs (<xref rid="B56" ref-type="bibr">Glavinas et al., 2004</xref>; <xref rid="B68" ref-type="bibr">Holmes et al., 2012</xref>). This approach represents a hopeful option for effective chemotherapy and a pivotal strategy to overwhelm clinical MDR outcomes.</p></sec><sec><title>Drug Detoxification</title><p>A substantial group of genes involved in cellular detoxification is activated when fungi are challenged with cytotoxic drugs at sub-inhibitory concentrations, which contributes to increasing the tolerance to these drugs. RNA-sequencing (RNA-Seq) analysis of the effect of acriflavine (ACR) on <italic>T. rubrum</italic> showed that genes involved in cellular detoxification were highly up-regulated, including those encoding catalases that protect the cell against oxidative stress and reactive oxygen species (<xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>). The increased expression of catalase genes may constitute a compensatory mechanism to maintain the intracellular level of this enzyme, thus protecting the cells from apoptotic effects elicited by the drug. Conversely, catalase activity is inhibited by acriflavine <italic>in vitro</italic>. Moreover, RNA-Seq analysis of the differential gene expression of <italic>T. rubrum</italic> challenged with UDA also revealed the up-regulation of several genes coding for antioxidant enzymes. In addition to catalases, superoxide dismutase, peroxidases, glutathione transferases, and glutathione peroxidases were identified as being stimulated in response to UDA, leading to enzymatic oxidative detoxification of the fungal cells (<xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). Consistent with these findings, a previous report also suggested that <italic>Candida</italic> resistance to amphotericin B (AMB) might be mediated by increased catalase activity as well (<xref rid="B124" ref-type="bibr">Peman et al., 2009</xref>).</p><p>The ability of a fungus to secrete enzymes is related to its pathogenicity and stress response as well as its mechanisms of detoxification. <italic>T. rubrum</italic> secretes esterases and other enzymes depending on the nutrients supplied (<xref rid="B14" ref-type="bibr">Brasch et al., 1991</xref>). Furthermore, the electrophoretic pattern of esterases secreted from <italic>T. rubrum</italic> revealed new isoforms when this dermatophyte was grown in sub-inhibitory concentrations of GRS and tioconazole (<xref rid="B42" ref-type="bibr">Fachin et al., 2001</xref>). These additional forms of esterase may participate in the cellular detoxification directly or may comprise a non-specific cellular response to stress leading to drug tolerance. The participation of esterase in detoxification leading to drug resistance has already been described in other organisms (<xref rid="B62" ref-type="bibr">Harms et al., 1996</xref>; <xref rid="B137" ref-type="bibr">Rooker et al., 1996</xref>).</p><p>Overexpression of target enzymes is also found in several azole-resistant strains, which is a compensatory mechanism for ergosterol depletion. Overexpression of <italic>erg11</italic> occurs in <italic>C. albicans</italic> through duplication of the left arm of chromosome 5, which harbors the <italic>erg11</italic> gene (<xref rid="B32" ref-type="bibr">Cowen et al., 2015</xref>; <xref rid="B140" ref-type="bibr">Sanglard, 2016</xref>). <italic>Cryptococcus neoformans</italic> adapts to high concentrations of FLC by the formation of chromosome 1 disomies. This resistance is a consequence of the duplication of two genes that are located on this chromosome: ERG11, the target of FLC and AFR1, a transporter of azoles in <italic>C. neoformans</italic> (<xref rid="B155" ref-type="bibr">Sionov et al., 2010</xref>). Also, extra copies of the <italic>A. fumigatus</italic> squalene epoxidase gene confer resistance to terbinafine (<xref rid="B94" ref-type="bibr">Liu et al., 2004</xref>). However, extra copies of the salicylate 1-monooxygenase (<italic>salA</italic>) gene were suggested to be the cause of terbinafine resistance in <italic>Aspergillus nidulans</italic>, although this enzyme does not represent the target of this drug. Instead, the authors hypothesized that the cleavage of the naphthalene nucleus present in the molecular structure of terbinafine is responsible for its degradation and consequently the resistance phenotype (<xref rid="B58" ref-type="bibr">Graminha et al., 2004</xref>). Subsequently, a strain of <italic>T. rubrum</italic> was rendered resistant to terbinafine by transformation with multiple copies of the <italic>salA</italic> gene (<xref rid="B142" ref-type="bibr">Santos et al., 2018</xref>). This strain exhibited elevated expression of the <italic>salA</italic> gene and simultaneously increased resistance to terbinafine, compared to the original strain. Thus, these results showed that this gene plays a role in the resistance and response to terbinafine in dermatophytes. However, the resistant phenotype was reversed after the strain was cultured in the absence of terbinafine for several generations, thereby losing plasmids containing the <italic>salA</italic> gene, which confirmed that extra copies of this gene provoked resistance. Moreover, the original strain without any plasmid responded to the challenge with terbinafine by increasing the expression of the endogenous <italic>salA</italic> gene (<xref rid="B142" ref-type="bibr">Santos et al., 2018</xref>).</p><p>Unlike bacteria, which exhibit several examples of antibiotic resistance through the degradation of these compounds, the resistance of fungi to antifungal agents by inactivation or degradation is a not well known (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>). Taking into account that fungi secrete a large number of enzymes (<xref rid="B100" ref-type="bibr">Martinez-Rossi et al., 2017</xref>), it is probable that similar mechanisms resulting in resistance or tolerance to antifungal may be frequent. The disclosure of fungal enzymes having this role may thus be useful for the development of enzyme inhibitors, which could be applied alone or in association with conventional therapy.</p></sec><sec><title>Transcriptional Modulation of Kinase Genes</title><p>Genome-wide expression profiling has provided new targets for the development of novel drugs by the pharmaceutical industries and increased the general understanding regarding the mechanisms of action of different drugs and their therapeutic effects. Several studies have revealed the existence of various regulatory and metabolic circuits necessary to develop resistance to antifungal agents (<xref rid="B141" ref-type="bibr">Sanglard et al., 2009</xref>). Considering the nature of the pathogen stress-response systems and that some cellular proteins related to these mechanisms are phosphorylated, protein kinases may represent a potential target for antifungal drug therapy (<xref rid="B52" ref-type="bibr">Garaizar et al., 2006</xref>). In particular, protein phosphorylation is known to trigger several signaling transduction pathways involved in cell stimuli propagation. Thus, several groups have been exploring different genetic approaches to investigate the expression of kinases responsive to different drugs, with the purpose of obtaining a better understanding of dermatophyte resistance to antifungal agents.</p><p>For example, a microarray hybridization approach was applied in the analysis of gene expression responses of dermatophytes exposed to several antifungal agents. <italic>T. rubrum</italic> was exposed to sub-inhibitory concentrations of the antifungal agents ketoconazole and AMB (<xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref>). The authors reported the down-regulation of four kinase genes in response to AMB, highlighting two genes coding for MAP kinases (MpkA and STE7). Notably, these proteins belong to different stress-responsive pathways. The authors also reported a down-regulated kinase gene in response to AMB, coding for a serine/threonine protein kinase (<italic>sps1</italic>). This protein is important for transcriptional, biochemical, and morphological events during the later events of fungal sporulation (<xref rid="B50" ref-type="bibr">Friesen et al., 1994</xref>; <xref rid="B168" ref-type="bibr">Widmann et al., 1999</xref>; <xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref>). Conversely, <italic>T. rubrum</italic> cultivated in the presence of terbinafine showed an up-regulation of the kinase gene <italic>sps1</italic> (<xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref>). These authors have also reported a significant down-regulation of two-phosphorylated-intermediary-components involved in regulating a MAP kinase cascade, as well as a predicted unusual protein kinase (<xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref>; <xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref>).</p><p>In addition, the same group analyzed the transcription of <italic>T. rubrum</italic> genes in response to PHS11A and PH11B, inhibitors of synthesized fatty acid synthase (FAS), which was chosen as an interesting antifungal target owing to architectural differences between the mammalian and fungal protein. Four kinase genes were negatively modulated in response to PHS11A: <italic>pkaC, ssp1</italic>, and <italic>sln1</italic>, which are related to signal transduction pathways, and a putative dihydroxyacetone kinase (DAK2), related to carbohydrate transport and metabolism. Only one kinase gene (<italic>bck1</italic>) showed up-regulation in the presence of PHS11A. <italic>Bck1</italic> was also responsive to TRB (<xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref>, <xref rid="B179" ref-type="bibr">2009</xref>). In turn, PH11B up-regulated two kinase genes, the pyrophosphate-dependent phosphofructo-1-kinase gene (<italic>pfk1</italic>) and a hexokinase gene (<italic>glk1</italic>). Both genes are related to carbohydrate transport and metabolism (<xref rid="B175" ref-type="bibr">Yu et al., 2007a</xref>).</p><p>Up-regulation of the MAP kinase gene (<italic>mpka</italic>) in the presence of itraconazole has also been reported (<xref rid="B39" ref-type="bibr">Diao et al., 2009</xref>). This gene was also down-regulated in response to AMB, being related to cell wall integrity. Thus, the authors argued that the stress caused by this antifungal agent in the ergosterol pathway, and consequently in the plasma membrane, can be compensated by the activation of the cell wall integrity pathway, altering the structure and composition of the fungal cell wall (<xref rid="B74" ref-type="bibr">Jung and Levin, 1999</xref>; <xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref>; <xref rid="B39" ref-type="bibr">Diao et al., 2009</xref>).</p><p>Moreover, a suppressive subtractive hybridization approach was used to identify genes differentially expressed after the exposure of <italic>T. rubrum</italic> to the cytotoxic drugs ACR, fluconazole (FLC), GRS, TRB, and UDA (<xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>). The authors described the up-regulation of the never in mitosis A (<italic>nima</italic>) gene in response to FLC, GRS, and TRB. This gene was also up-regulated in <italic>T. rubrum</italic> under acidic pH and growth in keratin as the only carbon source (<xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>; <xref rid="B126" ref-type="bibr">Peres et al., 2010b</xref>). The NIMA kinase family, initially isolated from <italic>A. nidulans</italic>, is required for the G2/M transition. Mammalian NIMA-related kinase 11, long and short isoform (<italic>nek11L</italic> and <italic>nek11S</italic>) genes are related to DNA replication/damage stress response, being also expressed in response to unspecific cellular stresses (<xref rid="B121" ref-type="bibr">Osmani et al., 1988</xref>; <xref rid="B116" ref-type="bibr">Noguchi et al., 2002</xref>; <xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref>; <xref rid="B126" ref-type="bibr">Peres et al., 2010b</xref>).</p><p>Differential display RT-PCR and northern blot techniques have been used to analyze <italic>T. rubrum</italic> molecular responses to acriflavine as well, showing increased transcription levels of a gene coding for a putative riboflavin kinase. This enzyme is essential in the flavin biosynthetic pathway, catalyzing the first step of this process yielding flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). This pathway is crucial for several biological processes including lipid, protein, and carbohydrate metabolism (<xref rid="B143" ref-type="bibr">Santos et al., 2000</xref>; <xref rid="B147" ref-type="bibr">Segato et al., 2008</xref>).</p><p>In turn, a high-throughput RNA-Seq approach was applied to evaluate the time-dependent effects of acriflavine on the <italic>T. rubrum</italic> transcriptome. In 3 h of drug exposure, four kinase genes responded to acriflavine, two being up- (<italic>adenosine 5&#x02032;-phosphosulfate kinase</italic> and <italic>homoserine kinase</italic>) and two down-regulated (protein kinase subdomain-containing protein, and pyridoxine kinase). In 12 h of exposure, only one kinase gene was up-regulated (<italic>cmgc/srpk protein kinase</italic>). In 24 h of exposure, four kinase genes were up-regulated, highlighting the genes coding for a calcium-calmodulin-dependent pathway, indicating that acriflavine probably affects this signaling route in <italic>T. rubrum</italic>, which is reported to be involved in cell survival under stressful conditions (<xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>). Moreover, in 24 h of exposure, five kinase genes were down-regulated. Notably, acriflavine repressed an unusual kinase gene (coding for an atypical/ABC1/ABC1-B protein kinase) that does not display most of the typical eukaryotic protein kinase features, being reported as a chloroplast or mitochondria-related protein that regulates quinone synthesis (<xref rid="B70" ref-type="bibr">Huang et al., 2015</xref>). In addition, a gene coding for a kinase subdomain-containing protein was strongly up-regulated upon acriflavine exposure (<xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>).</p><p>Recently, RNA-Seq analysis also revealed interesting data related to the response of <italic>T. rubrum</italic> to sub-lethal doses of UDA (<xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). In this study, three kinase genes were up-regulated including the uridine/cytidine kinase (<italic>uck</italic>), <italic>ste/ste7</italic> (<italic>ste7</italic>) protein kinase, and dephospho-CoA kinase (<italic>dpck</italic>). UCK is involved in the conversion of both cytidine and uridine to nucleoside monophosphate. STE7 is associated with the MAPK pathway, and DPCK is involved with the final steps of the pathway for CoA biosynthesis (<xref rid="B165" ref-type="bibr">Wadler and Cronan, 2007</xref>; <xref rid="B163" ref-type="bibr">Tomoike et al., 2017</xref>; <xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). One gene was down-regulated (nucleoside diphosphate kinase) in the early response to UDA (3 h). At 12 h of exposure to UDA, two distinct serine/threonine protein kinase coding genes were down-regulated. Furthermore, the authors reported two kinase genes responding to UDA in both 3 and 12 h of drug exposure; one was another distinct serine/threonine protein kinase coding gene, showing a strong down-regulation. The other was AGC/RSK protein kinase, which was also down-regulated in response to acriflavine (<xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>; <xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>). AGC protein kinase (a subgroup of the Ser/Thr protein kinases) was named based on sequence alignments of the catalytic domain with the cAMP-dependent protein kinase 1 (PKA), cGMP-dependent protein kinase (PKG), and protein kinase C. Notably, ribosomal S6 kinase (RSK), a member of the AGC family, contains two kinase catalytic domains in the same polypeptide. Thus, in addition to the AGC kinase domain at the N-terminal portion, the C-terminus displays a calcium/calmodulin dependent kinase domain that is activated by the extracellular signal-regulated kinase (eRK) pathway and plays an important role in protein synthesis (<xref rid="B123" ref-type="bibr">Pearce et al., 2010</xref>). All of these kinase genes/proteins described above are listed in <bold>Table <xref ref-type="table" rid="T3">3</xref></bold>.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Relation of <italic>T. rubrum</italic> kinase genes modulated by antifungal agents.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Gene product name</th><th valign="top" align="left" rowspan="1" colspan="1">ID</th><th valign="top" align="left" rowspan="1" colspan="1">Antifungals</th><th valign="top" align="left" rowspan="1" colspan="1">Modulation</th><th valign="top" align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase (MpkA)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00832</td><td valign="top" align="left" rowspan="1" colspan="1">AMB, ITRA</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated, Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref>, <xref rid="B39" ref-type="bibr">Diao et al., 2009</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase (STE7)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_02515</td><td valign="top" align="left" rowspan="1" colspan="1">AMB</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase (SPS1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00281</td><td valign="top" align="left" rowspan="1" colspan="1">AMB</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B176" ref-type="bibr">Yu et al., 2007b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">cAMP-dependent protein kinase catalytic subunit (PKaC)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_03685</td><td valign="top" align="left" rowspan="1" colspan="1">PHS11A</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Suppressor of sensor kinase (SLN1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_06080</td><td valign="top" align="left" rowspan="1" colspan="1">PHS11A</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase (SSP1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_05979</td><td valign="top" align="left" rowspan="1" colspan="1">PHS11A</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dihydroxyacetone kinase (DAK2)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_08455</td><td valign="top" align="left" rowspan="1" colspan="1">PHS11A</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase (BCK1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00207</td><td valign="top" align="left" rowspan="1" colspan="1">PHS11A</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B178" ref-type="bibr">Zhang et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pyrophosphate-dependent phosphofructo-1-kinase (PFK1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_05437</td><td valign="top" align="left" rowspan="1" colspan="1">PH11B</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B175" ref-type="bibr">Yu et al., 2007a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hexokinase (GLK1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_08933</td><td valign="top" align="left" rowspan="1" colspan="1">PH11B</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B175" ref-type="bibr">Yu et al., 2007a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Never in mitosis A kinase (NIMA)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_06149</td><td valign="top" align="left" rowspan="1" colspan="1">FLC, GRS or TRB</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B122" ref-type="bibr">Pai&#x000e3;o et al., 2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Riboflavin kinase (FMN1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_03281</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B147" ref-type="bibr">Segato et al., 2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pyridoxine kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_06151</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adenosine 5&#x02019;-phosphosulfate kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_07921</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kinase subdomain-containing protein</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_07159</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kinase subdomain-containing protein</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_02787</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kinase subdomain-containing protein</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_01497</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mitogen-activated protein kinase (MAF1)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00595</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CMGC/SRPK protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_08979</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Calcium-calmodulin-dependent protein kinase (CamK)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_02198</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAMKK protein kinase (CamKK)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_07555</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stress activated MAP kinase interacting protein</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_03684</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Atypical/ABC1/ABC1-B protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_07639</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_04042</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_07140</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Thiamine pyrophosphokinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_05058</td><td valign="top" align="left" rowspan="1" colspan="1">ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Uridine/cytidine kinase (UCK)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_05622</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">STE/STE7 protein kinase (STE7)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_08066</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dephospho-CoA kinase (DPCK<italic>)</italic></td><td valign="top" align="left" rowspan="1" colspan="1">TERG_04392</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nucleoside diphosphate kinase (NDK)</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_04558</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_08278</td><td valign="top" align="left" rowspan="1" colspan="1">UDA/ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>; <xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00199</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serine/threonine protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_03851</td><td valign="top" align="left" rowspan="1" colspan="1">UDA</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AGC/RSK protein kinase</td><td valign="top" align="left" rowspan="1" colspan="1">TERG_00281</td><td valign="top" align="left" rowspan="1" colspan="1">UDA/ACR</td><td valign="top" align="left" rowspan="1" colspan="1">Down-regulated</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B128" ref-type="bibr">Persinoti et al., 2014</xref>; <xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref></td></tr></tbody></table><table-wrap-foot><attrib><italic>Drugs: ACR, acriflavine; AMB, amphotericin B; FLC, fluconazole; GRS, griseofulvin; ITRA, itraconazole; TRB, terbinafine; UDA, undecanoic acid, and PHS11A and PH11B.</italic></attrib></table-wrap-foot></table-wrap></sec><sec><title>Fungal Heat Shock Proteins</title><p>Initially discovered in <italic>Drosophila</italic> (<xref rid="B34" ref-type="bibr">De Maio et al., 2012</xref>), the heat shock proteins (Hsps) comprise chaperones present in all organisms studied to date that participate in diverse cellular processes such as transcription, translation, post-translational modifications, protein folding, and protein aggregation and disaggregation (<xref rid="B162" ref-type="bibr">Tiwari et al., 2015</xref>). Some Hsps may be induced when cells undergo stressful conditions, such as the exposure to antifungal agents, and extremes of temperature or pH (<xref rid="B154" ref-type="bibr">Singh et al., 2009</xref>; <xref rid="B89" ref-type="bibr">Leach et al., 2012a</xref>; <xref rid="B160" ref-type="bibr">Tamayo et al., 2013</xref>; <xref rid="B162" ref-type="bibr">Tiwari et al., 2015</xref>). These proteins are classified according to their functions and molecular mass into six families: Hsp40, Hsp60, Hsp70, Hsp90, Hsp100, and small Hsps (<xref rid="B162" ref-type="bibr">Tiwari et al., 2015</xref>). In fungi, Hsp20-40, Hsp70, and Hsp90 are predominant and participate in several cellular events, with some Hsps acting as co-chaperones (<xref rid="B49" ref-type="bibr">Fink, 1999</xref>; <xref rid="B162" ref-type="bibr">Tiwari et al., 2015</xref>). In <italic>C. albicans</italic>, low molecular mass Hsps are ATP independent, whereas those with higher molecular mass are ATP dependent (<xref rid="B57" ref-type="bibr">Gong et al., 2017</xref>). Usually, the <italic>hsp</italic> genes are activated by a heat shock transcription factor (HSF). This protein under stress conditions is phosphorylated and trimerized, binding to the promoter regions of the <italic>hsp</italic> genes and inducing their transcription (<xref rid="B2" ref-type="bibr">Akerfelt et al., 2010</xref>).</p><p>The relationship between the gene expression of <italic>hsp</italic> genes and the stress induced by antifungal drugs has been evidenced in different pathogenic agents including yeasts and filamentous fungi (<xref rid="B162" ref-type="bibr">Tiwari et al., 2015</xref>). In dermatophytes, the exposure to sub-lethal doses of diverse cytotoxic drugs results in the modulation of several <italic>hsp</italic> genes (<xref rid="B99" ref-type="bibr">Martinez-Rossi et al., 2016</xref>). Drug stress induces the up-regulation of genes encoding proteins belonging mainly to the Hsp70 family, such as in response to TRB, PHS11A, and ACR, or belonging to the small Hsp family, such as in response to TRB, AMB, ITR, and ACR (<xref rid="B73" ref-type="bibr">Jacob et al., 2015</xref>; <xref rid="B99" ref-type="bibr">Martinez-Rossi et al., 2016</xref>). Hsp70 proteins are monomeric and collaborate with the Hsp40 family of co-chaperones to bind to linear segments of unfolded proteins, whereas small Hsps form oligomeric complexes that bind to denatured proteins (<xref rid="B146" ref-type="bibr">Schopf et al., 2017</xref>). The genes encoding Hsp90 (<xref rid="B73" ref-type="bibr">Jacob et al., 2015</xref>), Cdc37, and the transcription factor Hsf1 (<xref rid="B99" ref-type="bibr">Martinez-Rossi et al., 2016</xref>) are up-regulated in <italic>T. rubrum</italic> in response to TRB and ACR. Cdc37 is one of the co-chaperones that regulates Hsp90 function, playing roles in the maturation of kinases (<xref rid="B146" ref-type="bibr">Schopf et al., 2017</xref>). Additionally, the genes encoding the transcriptional regulator Hsf1 and PacC are upregulated when <italic>T. rubrum</italic> and <italic>T. interdigitale</italic> are submitted to temperature shifts in keratin cultures. In a pacC<sup>-</sup> strain of <italic>T. interdigitale</italic> the transcription of the <italic>hsf1</italic> gene was tightly reduced compared to the other <italic>hsp</italic> genes. The authors suggested that the collaboration between PacC and Hsf1 proteins modulates the level of <italic>hsp</italic> transcripts in response to cellular stress (<xref rid="B99" ref-type="bibr">Martinez-Rossi et al., 2016</xref>). In contrast, <italic>T. rubrum</italic> challenged with sub-inhibitory concentrations of UDA for 3 and 12 h did not significantly increase the expression of any <italic>hsp</italic> gene (<xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>), indicating that the cell used another strategy to cope with the stress provoked by this drug. In support of this, other pathways were also highlighted during UDA detoxification in <italic>T. rubrum</italic> such as those involved in lipid metabolism, cellular membrane composition, pathogenesis, and oxidative stress. Moreover, events of alternative splicing, including intron retention and exon skipping, were described in response to UDA as well (<xref rid="B106" ref-type="bibr">Mendes et al., 2018</xref>).</p><p>Hsp90, one of the most conserved Hsps, associates with a wide range of client proteins, controlling their activities by folding them to their active conformations. Clients are enriched in signal transducers including kinases and transcription factors (<xref rid="B159" ref-type="bibr">Taipale et al., 2010</xref>; <xref rid="B89" ref-type="bibr">Leach et al., 2012a</xref>). In <italic>S. cerevisiae</italic>, Hsp90 interacts with approximately 10% of the yeast proteome (<xref rid="B180" ref-type="bibr">Zhao et al., 2005</xref>; <xref rid="B90" ref-type="bibr">Leach et al., 2012b</xref>). By controlling the activation of key molecules, Hsp90 plays roles in diverse processes including morphogenetic changes, stress adaptation, and antifungal resistance (<xref rid="B30" ref-type="bibr">Cowen, 2009</xref>; <xref rid="B154" ref-type="bibr">Singh et al., 2009</xref>; <xref rid="B87" ref-type="bibr">Lamoth et al., 2016</xref>). In yeast, it was established that Hsp90 potentiates azole resistance in <italic>C. albicans</italic> and <italic>Saccharomyces cerevisiae</italic> (<xref rid="B31" ref-type="bibr">Cowen and Lindquist, 2005</xref>; <xref rid="B30" ref-type="bibr">Cowen, 2009</xref>), in addition to governing the cellular circuits required for resistance to echinocandins in <italic>C. albicans</italic> (<xref rid="B154" ref-type="bibr">Singh et al., 2009</xref>). This biological response occurs through the activation of calcineurin phosphatase by Hsp90 under stress conditions (<xref rid="B29" ref-type="bibr">Cowen, 2008</xref>; <xref rid="B154" ref-type="bibr">Singh et al., 2009</xref>). In <italic>A. fumigatus</italic>, the genetic repression of Hsp90 showed that this chaperone appears to be essential for the development of this fungus, causing a decrease in spore viability, reduction in hyphae growth, and defects in germination (<xref rid="B86" ref-type="bibr">Lamoth et al., 2012</xref>). Some information about the cellular location of Hsp90 in different pathogenic fungi may help to understand the biological functionality of this protein against toxic agents. In <italic>C. neoformans</italic>, Hsp90 is located on the cell surface, so that the inhibition of this protein confers the natural resistance to cell wall inhibitors (<xref rid="B22" ref-type="bibr">Chatterjee and Tatu, 2017</xref>). However, in <italic>A. fumigatus</italic>, Hsp90 is predominantly found in the cytosol, although in the presence of cell wall stressors it accumulates in the cell wall and the septa regions of the hypha, indicating an activity in compensatory stress mechanisms (<xref rid="B86" ref-type="bibr">Lamoth et al., 2012</xref>).</p><p>However, despite the well-established data regarding Hsp90 in drug-induced responses in several fungi, few studies have addressed protein interactions and their biological role in dermatophytes. For example, the chemical inhibition of Hsp90 of <italic>T. rubrum</italic> caused increased susceptibility to micafungin and itraconazole, and improved the efficacy of these antifungal agents. Additionally, Hsp90 inhibition impaired fungal growth in human nail fragments and altered the modulation of other <italic>hsp</italic> genes as well as the <italic>pacC</italic> gene, which encodes a transcription factor involved in fungal pathogenicity (<xref rid="B11" ref-type="bibr">Bignell et al., 2005</xref>; <xref rid="B48" ref-type="bibr">Ferreira-Nozawa et al., 2006</xref>), suggesting that Hsp90 is involved in both pathogenicity and drug susceptibility in <italic>T. rubrum</italic> (<xref rid="B73" ref-type="bibr">Jacob et al., 2015</xref>). In this case, the synergism observed between the inhibition of Hsp90 and the increased susceptibility to some antifungal in <italic>T. rubrum</italic> revealed Hsp90 as a novel target and its inhibition as a potential strategy to treat dermatophytosis (<xref rid="B73" ref-type="bibr">Jacob et al., 2015</xref>).</p><p>Although they present a high degree of homology, the differences between Hsp90 orthologs may be explained owing to the occurrence of post-translational modifications that can interfere in the differential regulation of these proteins (<xref rid="B87" ref-type="bibr">Lamoth et al., 2016</xref>). Considering the participation of Hsp90 in the development of drug resistance, drugs targeting this chaperone have been recognized as new therapeutic alternatives against pathogenic fungi. Currently, inhibitors and anti-Hsp90 antibodies have been shown to interfere with the activity of Hsp90 (<xref rid="B57" ref-type="bibr">Gong et al., 2017</xref>) by binding to the N-terminal region in the ATP binding site (<xref rid="B92" ref-type="bibr">Li et al., 2015</xref>); these agents include radicicol (RAD), geldanamycin (GdA), GdA analogs, and non-GdA Hsp90 inhibitors (<xref rid="B57" ref-type="bibr">Gong et al., 2017</xref>). However, for pharmacological application in clinical therapy, the toxicity of these drugs must be carefully evaluated in humans (<xref rid="B164" ref-type="bibr">Uehara, 2003</xref>) to avoid any potential for harm to patient health.</p></sec><sec><title>Mutations Affecting Drug Target Genes</title><p>Several mutations in genes encoding enzymes targeted by antifungal agents, mostly enzymes involved in ergosterol biosynthesis and cell wall synthesis, have been described in different fungal pathogens. Azoles inhibits lanosterol alfa-14-demethylase (Cyp51) by binding the nitrogen in the azoles ring to the iron atom of the heme group of the protein. This class of drugs is used for the treatment of several mycoses, including dermatophytosis, owing to its broad spectrum of activity; however, an increasing number of resistant isolates have arisen (<xref rid="B18" ref-type="bibr">Campoy and Adrio, 2017</xref>). Mutations in the <italic>erg11</italic> gene, which encodes the lanosterol alfa-14-demethylase, are often found in <italic>C. albicans</italic> azole-resistant clinical isolates, resulting in non-synonymous amino acid substitutions in regions close to the active site of the enzyme. Although inducing post-translational modifications that affect its three-dimensional structure (<xref rid="B111" ref-type="bibr">Morio et al., 2010</xref>), these mutations do not affect the enzyme function and are often followed by loss of heterozygosity, which increases azole resistance (<xref rid="B148" ref-type="bibr">Selmecki et al., 2010</xref>). Moreover, <italic>erg11</italic> mutations have different effects on the affinity of distinct azole drugs, which interact with specific Erg11 residues (<xref rid="B111" ref-type="bibr">Morio et al., 2010</xref>). Accordingly, a recent study demonstrated that some mutations alter the hydrogen bond between the drug and target protein, reducing the affinity of short-tailed but not of long-tailed triazoles (<xref rid="B138" ref-type="bibr">Sagatova et al., 2016</xref>).</p><p>Another target enzyme of antifungal agents is squalene epoxidase (SE), which participates in the ergosterol biosynthesis pathway by catalyzing the epoxidation of squalene to 2-3-oxidosqualene. Terbinafine, the drug of choice for dermatophytes, is an antifungal agent that inhibits SE fungal activity in a non-competitive way, leading to depletion of ergosterol and accumulation of squalene (<xref rid="B46" ref-type="bibr">Favre and Ryder, 1996</xref>). Mutations in the gene for SE that give rise to amino acid substitutions lead to structural changes and decreased binding of terbinafine to the protein without causing dysfunction in ergosterol biosynthesis (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>). Until recently, few <italic>T. rubrum</italic> clinical isolates resistant to terbinafine have been described, and only two clinical isolates were investigated and associated with SE mutations, which resulted in the amino acid substitutions L393F and F397L. Both isolates were cross-resistant to all tested SE inhibitors, with these mutations being in the same region as several mutations identified previously in terbinafine-resistant <italic>S. cerevisiae</italic> strains. In addition, the expression of <italic>C. albicans</italic> SE harboring mutations with corresponding amino acid substitutions was shown to decrease inhibitor susceptibility in <italic>S. cerevisiae</italic>; furthermore, single point mutations in <italic>A. nidulan</italic>s and <italic>A. fumigatus</italic> in amino acids corresponding to the F397L substitution were associated with terbinafine resistance (<xref rid="B120" ref-type="bibr">Osborne et al., 2005</xref>; <xref rid="B136" ref-type="bibr">Rocha et al., 2006</xref>; <xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>) These data therefore suggested that this region may contain the high-affinity site for TRB.</p><p>Recently, 2,056 isolates of <italic>T. rubrum</italic> and <italic>T. interdigitale</italic> were evaluated regarding to their susceptibility to TRB. The authors found that only 17 isolates, representing less than 1%, were resistant to TRB. By analyzing the gene sequence of the SE, they found point mutations in four positions responsible for the resistant phenotype, which are represented in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>. In addition to L393F and F397L, seven new mutations were identified including one in residue L393 and two in residue F397. These mutations were investigated through expression of the corresponding amino acid substitutions using <italic>Arthoderma vanbreuseghemii</italic> (<italic>T. mentagrophytes</italic>) as a recipient organism. The strains harboring mutated genes were less susceptible to TRB, with global gene expression analysis revealing no other significant differences between the mutated and control strains, indicating that the increased TRB resistance was due to the mutations (<xref rid="B173" ref-type="bibr">Yamada et al., 2017</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Alignment of amino acid sequences of squalene epoxidase (SE) of <italic>T. mentagrophytes, T. rubrum, A. fumigatus</italic>, and <italic>S. cerevisiae</italic>. The six residues with point mutations associated with terbinafine resistance are indicated by red contour. The boxes represent point mutations in SE from <italic>T. mentagrophytes</italic> and <italic>T. rubrum</italic> (blue), <italic>A. fumigatus</italic> (red), and <italic>S. cerevisiae</italic> (green). Asterisks are related to identical residues in the four species, whereas two dots or one dot represent a higher and lower degree of conservation, respectively.</p></caption><graphic xlink:href="fmicb-09-01108-g001"/></fig><p>The substitution in the amino acid corresponding to F415 in <italic>S. cerevisiae</italic> (F420) has been previously associated with TRB resistance (<xref rid="B101" ref-type="bibr">Martinez-Rossi et al., 2008</xref>), being the first mutation found in residue His440. A valine is located in the equivalent position (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>), which was not identified in a previous screening of critical amino acids by 3D modeling of <italic>S. cerevisiae</italic> SE (<xref rid="B118" ref-type="bibr">Nowosielski et al., 2011</xref>), owing to subtle conformational differences between the enzymes from <italic>S. cerevisiae</italic> and <italic>Trichophyton</italic> spp. Moreover, the high frequency of TRB resistant isolates in this study are considered to be related to the prolonged exposure during treatment, as eight among 17 patients had been previously treated with TRB (<xref rid="B173" ref-type="bibr">Yamada et al., 2017</xref>).</p><p>Currently, the increasing resistance to azoles in some <italic>Candida</italic> species has rendered echinocandins as the first line therapy for invasive candidiasis. This class of drugs inhibits the fks subunit of glucan synthases; accordingly, clinical resistance has been associated with mutations in fks-encoding genes. In <italic>C. glabrata</italic>, the majority of mutations are located in one of the two hot spot regions of <italic>fks</italic>1 and <italic>fks</italic>2, whereas in other <italic>Candida</italic> spp., these substitutions are encountered only in <italic>fks</italic>1, in two hot spot regions comprising residues Phe641&#x02013;Pro649 and Arg1361. The most abundant mutations that give rise to the most pronounced phenotypes in <italic>C. albicans</italic> are substitutions in Ser645 and Phe641 (<xref rid="B127" ref-type="bibr">Perlin, 2015</xref>). This mechanism of resistance to echinocandins has also been described for <italic>A. fumigatus</italic>, through S678P substitution in the Fks1 subunit. In addition, the reduced intrinsic susceptibility of the <italic>C. parapsilosis</italic> complex and <italic>C. guilliermondii</italic> involve the occurrence of polymorphisms in hot spot 1 of the Fks1 subunit, although the clinical significance is uncertain as these species are often successfully treated with echinocandins (<xref rid="B127" ref-type="bibr">Perlin, 2015</xref>; <xref rid="B40" ref-type="bibr">Dudiuk et al., 2017</xref>).</p><p>It is known that <italic>fks</italic>1 mutations can result in different therapeutic responses to different echinocandins and may or may not be associated with reduced virulence and fitness (<xref rid="B85" ref-type="bibr">Lackner et al., 2014</xref>; <xref rid="B127" ref-type="bibr">Perlin, 2015</xref>). Reduced virulence was previously related to altered kinetics of glucan synthase, resulting in changes in cell wall composition and decreased transmission between patients of strains harboring these mutations (<xref rid="B127" ref-type="bibr">Perlin, 2015</xref>). However, fitness may depend not only on the nature and position of the substitution but also on host immunity, as significant differences were found between immunocompetent and neutropenic hosts (<xref rid="B85" ref-type="bibr">Lackner et al., 2014</xref>).</p><p>Aside from the known consequences of <italic>fks</italic>1 mutations in echinocandin resistance, the functions of the Fks2 and Fks3 subunits are not yet entirely elucidated and may differ among species. Although echinocandin resistance in <italic>S. cerevisiae</italic> is conferred by <italic>fks</italic>2 mutations, both <italic>fks</italic>2 and <italic>fks</italic>3 deletion in this species resulted in better growth under exposure to caspofungin (<xref rid="B157" ref-type="bibr">Suwunnakorn et al., 2018</xref>). Moreover, a recent study demonstrated that Fks2 and Fks3 are not functionally redundant in <italic>C. albicans</italic> and suggested the action of both subunits as negative regulators of Fks1 (<xref rid="B157" ref-type="bibr">Suwunnakorn et al., 2018</xref>).</p><p>The <italic>in vitro</italic> efficacy of echinocandin drugs against dermatophytes was firstly evaluated by <xref rid="B9" ref-type="bibr">Bao et al. (2013)</xref>, who demonstrated that caspofungin and micafungin did not entirely inhibit growth, but exhibit good <italic>in vitro</italic> antifungal activity to dermatophytes. Recent studies also showed that anidulafungin has potent <italic>in vitro</italic> activity against dermatophytes although the relevance for clinical efficacy has not yet been established (<xref rid="B6" ref-type="bibr">Badali et al., 2015</xref>; <xref rid="B8" ref-type="bibr">Baghi et al., 2016</xref>; <xref rid="B38" ref-type="bibr">Deng et al., 2017</xref>). The absence of <italic>in vivo</italic> studies of echinocandins efficacy limits its use for treatment of dermatophytosis, which may underlie the absence of resistant dermatophyte strains described to date.</p></sec><sec><title>Structural Elements Influencing Drug Resistance</title><p>In addition to mechanisms involving stress and alteration of the target drug, other factors such as the fungal structure and cellular organization can also interfere with drug resistance/tolerance. For example, biofilms are comprised of complex, surface-associated cell populations embedded in an extracellular matrix and are considered the most prevalent forms of microbial growth. They are responsible for a broad spectrum of microbial infections in humans and are associated with increased resistance to antifungal therapy. Factors that contribute to biofilm drug resistance include structural complexity, presence of extracellular matrix, metabolic heterogeneity, and up-regulation of efflux pump genes. The matrix that surrounds the microbial population acts as a physical barrier, protecting the microbial community against drugs and host immune response and contributing to the emergence of persistent cells, a subpopulation able to tolerate higher concentrations of drugs and considered to enable recalcitrance (<xref rid="B45" ref-type="bibr">Fanning and Mitchell, 2012</xref>; <xref rid="B135" ref-type="bibr">Robbins et al., 2017</xref>). As recalcitrance is often associated with dermatophytosis, it has been proposed that biofilms may act as a source of persistent infection and antifungal resistance in onychomycosis (<xref rid="B16" ref-type="bibr">Burkhart et al., 2002</xref>; <xref rid="B59" ref-type="bibr">Gupta A.K. et al., 2016</xref>). Consistent with this concept, dermatophytes have been shown to form biofilms <italic>in vitro</italic> (<xref rid="B28" ref-type="bibr">Costa-Orlandi et al., 2014</xref>). Recently, the formation of biofilms in nail fragments has also been demonstrated in an <italic>in vitro</italic> model of onychomycosis (<xref rid="B15" ref-type="bibr">Brilhante et al., 2017</xref>).</p><p>The production of arthroconidia by dermatophytes has also been proposed to contribute to drug resistance. Arthroconidia are produced by the fragmentation of hyphae and are considered as the main mode of transmission of dermatophytosis (<xref rid="B60" ref-type="bibr">Gupta and Kohli, 2003</xref>). Arthroconidia are more resistant to antifungal drugs than hyphae (<xref rid="B5" ref-type="bibr">Arrese et al., 2001</xref>) and, in general, are more resistant than microconidia as well (<xref rid="B25" ref-type="bibr">Coelho et al., 2008</xref>).</p></sec></sec><sec><title>Conclusion and Perspectives</title><p>The ideal antifungal agent has been postulated as the compound that inhibits potential virulence factors, affects fungi physiology, and also acts on specific fungal cellular targets. Recently, the genomes of about twenty dermatophyte strains were sequenced through the Broad Institute initiative, and the databases are available at Broad Fungal FTP Site<sup><xref ref-type="fn" rid="fn01">1</xref></sup>. Consequently, advances in dermatophyte research have been reported, improving the understanding of their pathophysiology, niche and host preferences, and general aspects of gene structure and regulation, which together strongly contribute to the development of strategies for more effective therapies (<xref rid="B100" ref-type="bibr">Martinez-Rossi et al., 2017</xref>). Additionally, the comparative genome analysis highlighted the kinases as an enriched class in dermatophyte genomes, reemphasizing the interplay between signal transduction and regulation with dermatophyte&#x02013;host interaction (<xref rid="B98" ref-type="bibr">Martinez et al., 2012</xref>). Some such kinases, with unknown specificities, may be associated with intrinsic abilities of dermatophytes to cause disease. Here, we discussed the modulation of kinase-encoding genes in response to antifungal drugs along with their putative roles in drug-stress responses. Furthermore, the current studies shed light on potential novel antifungal targets such as the glyoxylate cycle, which is absent in mammalian cells and plays an adaptive role during infection (<xref rid="B96" ref-type="bibr">Lorenz and Fink, 2001</xref>). Another interesting target is FAS, owing to the marked architectural differences between fungal and mammalian FAS proteins, and to the importance of fatty acid biosynthesis for fungal physiology (<xref rid="B97" ref-type="bibr">Maier et al., 2010</xref>). Additionally, Hsp90 has been considered as a therapeutic target to treat fungal infections, as it is essential for cell physiology and participates in the response to several stresses including the exposure to antifungals as well as in fungal&#x02013;host interactions (<xref rid="B73" ref-type="bibr">Jacob et al., 2015</xref>; <xref rid="B99" ref-type="bibr">Martinez-Rossi et al., 2016</xref>, <xref rid="B100" ref-type="bibr">2017</xref>). Together, these potential targets play important roles in fungal adaptation, physiology, and the infection process. In this respect, both synthetic and natural compounds constitute promising sources of new structural entities with antifungal properties that exhibit potentially novel mechanisms of action. Moreover, these natural compounds may be administrated in association with conventional antifungal agents, synergistically enhancing their antifungal activity and acting as chemosensitizers to overcome fungal resistance. Therefore, the natural sources may expand the possibilities to improve or develop new and effective antifungal therapies.</p></sec><sec><title>Author Contributions</title><p>All authors reviewed literature and wrote sections of the manuscript. NM-R, TB, NP, EL, and AR edited the manuscript. TB and NQ designed the figure. TB, NP, and EG prepared the tables. All authors read and approved the submitted version.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank the Brazilian Agencies for the continuous support to our projects: FAPESP (proc. Nos. 2014/03847-7, 2015/23435-8, 2016/04274-6, 2011/08424-9, and others), CNPq (proc. Nos. 305797/2017-4 and 304989/2017-7), CAPES, and FAEPA.</p></ack><fn-group><fn id="fn01"><label>1</label><p><ext-link ext-link-type="ftp" xlink:href="ftp://ftp.broadinstitute.org/pub/annotation/fungi">ftp://ftp.broadinstitute.org/pub/annotation/fungi</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A. K.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Jacob</surname><given-names>M. R.</given-names></name><name><surname>Feng</surname><given-names>Q.</given-names></name><name><surname>Lorenz</surname><given-names>M. C.</given-names></name><name><surname>Walker</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine.</article-title>
<source><italic>Eukaryot. Cell</italic></source>
<volume>7</volume>
<fpage>387</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00323-07</pub-id>
<?supplied-pmid 18156292?><pub-id pub-id-type="pmid">18156292</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerfelt</surname><given-names>M.</given-names></name><name><surname>Morimoto</surname><given-names>R. I.</given-names></name><name><surname>Sistonen</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Heat shock factors: integrators of cell stress, development and lifespan.</article-title>
<source><italic>Nat. Rev. Mol. Cell Biol.</italic></source>
<volume>11</volume>
<fpage>545</fpage>&#x02013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2938</pub-id>
<?supplied-pmid 20628411?><pub-id pub-id-type="pmid">20628411</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendrup</surname><given-names>M. C.</given-names></name><name><surname>Jensen</surname><given-names>R. H.</given-names></name><name><surname>Cuenca-Estrella</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>In vitro</italic> activity of ASP2397 against <italic>Aspergillus</italic> isolates with or without acquired azole resistance mechanisms.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>60</volume>
<fpage>532</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02336-15</pub-id>
<?supplied-pmid 26552973?><pub-id pub-id-type="pmid">26552973</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arif</surname><given-names>T.</given-names></name><name><surname>Bhosale</surname><given-names>J. D.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Mandal</surname><given-names>T. K.</given-names></name><name><surname>Bendre</surname><given-names>R. S.</given-names></name><name><surname>Lavekar</surname><given-names>G. S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Natural products&#x02013;antifungal agents derived from plants.</article-title>
<source><italic>J. Asian Nat. Prod. Res.</italic></source>
<volume>11</volume>
<fpage>621</fpage>&#x02013;<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1080/10286020902942350</pub-id>
<?supplied-pmid 20183299?><pub-id pub-id-type="pmid">20183299</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrese</surname><given-names>J. E.</given-names></name><name><surname>Pierard-Franchimont</surname><given-names>C.</given-names></name><name><surname>Pierard</surname><given-names>G. E.</given-names></name></person-group> (<year>2001</year>). <article-title>A plea to bridge the gap between antifungals and the management of onychomycosis.</article-title>
<source><italic>Am. J. Clin. Dermatol.</italic></source>
<volume>2</volume>
<fpage>281</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.2165/00128071-200102050-00002</pub-id>
<?supplied-pmid 11721646?><pub-id pub-id-type="pmid">11721646</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badali</surname><given-names>H.</given-names></name><name><surname>Mohammadi</surname><given-names>R.</given-names></name><name><surname>Mashedi</surname><given-names>O.</given-names></name><name><surname>De Hoog</surname><given-names>G. S.</given-names></name><name><surname>Meis</surname><given-names>J. F.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>In vitro</italic> susceptibility patterns of clinically important <italic>Trichophyton</italic> and <italic>Epidermophyton</italic> species against nine antifungal drugs.</article-title>
<source><italic>Mycoses</italic></source>
<volume>58</volume>
<fpage>303</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1111/myc.12315</pub-id>
<?supplied-pmid 25757042?><pub-id pub-id-type="pmid">25757042</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Moon</surname><given-names>K.</given-names></name><name><surname>Nam</surname><given-names>S. J.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Oh</surname><given-names>K. B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Mohangamides A and B, new dilactone-tethered pseudo-dimeric peptides inhibiting <italic>Candida albicans</italic> isocitrate lyase.</article-title>
<source><italic>Org. Lett.</italic></source>
<volume>17</volume>
<fpage>712</fpage>&#x02013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1021/ol5037248</pub-id>
<?supplied-pmid 25622093?><pub-id pub-id-type="pmid">25622093</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baghi</surname><given-names>N.</given-names></name><name><surname>Shokohi</surname><given-names>T.</given-names></name><name><surname>Badali</surname><given-names>H.</given-names></name><name><surname>Makimura</surname><given-names>K.</given-names></name><name><surname>Rezaei-Matehkolaei</surname><given-names>A.</given-names></name><name><surname>Abdollahi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title><italic>In vitro</italic> activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>54</volume>
<fpage>757</fpage>&#x02013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myw016</pub-id>
<?supplied-pmid 27118804?><pub-id pub-id-type="pmid">27118804</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>Y. Q.</given-names></name><name><surname>Wan</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>R. Y.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>In vitro</italic> antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>175</volume>
<fpage>141</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-012-9571-6</pub-id>
<?supplied-pmid 22983900?><pub-id pub-id-type="pmid">22983900</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Yaakov</surname><given-names>D.</given-names></name><name><surname>Rivkin</surname><given-names>A.</given-names></name><name><surname>Mircus</surname><given-names>G.</given-names></name><name><surname>Albert</surname><given-names>N.</given-names></name><name><surname>Dietl</surname><given-names>A. M.</given-names></name><name><surname>Kovalerchick</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>71</volume>
<fpage>946</fpage>&#x02013;<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkv446</pub-id>
<?supplied-pmid 26747101?><pub-id pub-id-type="pmid">26747101</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignell</surname><given-names>E.</given-names></name><name><surname>Negrete-Urtasun</surname><given-names>S.</given-names></name><name><surname>Calcagno</surname><given-names>A. M.</given-names></name><name><surname>Haynes</surname><given-names>K.</given-names></name><name><surname>Arst</surname><given-names>H. N.</given-names></name><name><surname>Rogers</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>The <italic>Aspergillus</italic> pH-responsive transcription factor PacC regulates virulence.</article-title>
<source><italic>Mol. Microbiol.</italic></source>
<volume>55</volume>
<fpage>1072</fpage>&#x02013;<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04472.x</pub-id>
<?supplied-pmid 15686555?><pub-id pub-id-type="pmid">15686555</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitencourt</surname><given-names>T. A.</given-names></name><name><surname>Komoto</surname><given-names>T. T.</given-names></name><name><surname>Massaroto</surname><given-names>B. G.</given-names></name><name><surname>Miranda</surname><given-names>C. E.</given-names></name><name><surname>Beleboni</surname><given-names>R. O.</given-names></name><name><surname>Marins</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Trans-chalcone and quercetin down-regulate fatty acid synthase gene expression and reduce ergosterol content in the human pathogenic dermatophyte <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>BMC Complement. Altern. Med.</italic></source>
<volume>13</volume>:<issue>229</issue>. <pub-id pub-id-type="doi">10.1186/1472-6882-13-229</pub-id>
<?supplied-pmid 24044691?><pub-id pub-id-type="pmid">24044691</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeck</surname><given-names>P.</given-names></name><name><surname>Leal</surname><given-names>P. C.</given-names></name><name><surname>Yunes</surname><given-names>R. A.</given-names></name><name><surname>Filho</surname><given-names>V. C.</given-names></name><name><surname>Lopez</surname><given-names>S.</given-names></name><name><surname>Sortino</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones.</article-title>
<source><italic>Arch. Pharm.</italic></source>
<volume>338</volume>
<fpage>87</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/ardp.200400929</pub-id>
<?supplied-pmid 15799012?><pub-id pub-id-type="pmid">15799012</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasch</surname><given-names>J.</given-names></name><name><surname>Martins</surname><given-names>B. S.</given-names></name><name><surname>Christophers</surname><given-names>E.</given-names></name></person-group> (<year>1991</year>). <article-title>Enzyme release by <italic>Trichophyton rubrum</italic> depends on nutritional conditions.</article-title>
<source><italic>Mycoses</italic></source>
<volume>34</volume>
<fpage>365</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0507.1991.tb00795.x</pub-id>
<?supplied-pmid 1726475?><pub-id pub-id-type="pmid">1726475</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brilhante</surname><given-names>R. S. N.</given-names></name><name><surname>Correia</surname><given-names>E. E. M.</given-names></name><name><surname>Guedes</surname><given-names>G. M. M.</given-names></name><name><surname>Pereira</surname><given-names>V. S.</given-names></name><name><surname>Oliveira</surname><given-names>J. S.</given-names></name><name><surname>Bandeira</surname><given-names>S. P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Quantitative and structural analyses of the <italic>in vitro</italic> and <italic>ex vivo</italic> biofilm-forming ability of dermatophytes.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>66</volume>
<fpage>1045</fpage>&#x02013;<lpage>1052</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000528</pub-id>
<?supplied-pmid 28708048?><pub-id pub-id-type="pmid">28708048</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>C. N.</given-names></name><name><surname>Burkhart</surname><given-names>C. G.</given-names></name><name><surname>Gupta</surname><given-names>A. K.</given-names></name></person-group> (<year>2002</year>). <article-title>Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm.</article-title>
<source><italic>J. Am. Acad. Dermatol.</italic></source>
<volume>47</volume>
<fpage>629</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1067/mjd.2002.124699</pub-id>
<?supplied-pmid 12271316?><pub-id pub-id-type="pmid">12271316</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burmester</surname><given-names>A.</given-names></name><name><surname>Shelest</surname><given-names>E.</given-names></name><name><surname>Glockner</surname><given-names>G.</given-names></name><name><surname>Heddergott</surname><given-names>C.</given-names></name><name><surname>Schindler</surname><given-names>S.</given-names></name><name><surname>Staib</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi.</article-title>
<source><italic>Genome Biol.</italic></source>
<volume>12</volume>:<issue>R7</issue>. <pub-id pub-id-type="doi">10.1186/gb-2011-12-1-r7</pub-id>
<?supplied-pmid 21247460?><pub-id pub-id-type="pmid">21247460</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campoy</surname><given-names>S.</given-names></name><name><surname>Adrio</surname><given-names>J. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Antifungals.</article-title>
<source><italic>Biochem. Pharmacol.</italic></source>
<volume>133</volume>
<fpage>86</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2016.11.019</pub-id>
<?supplied-pmid 27884742?><pub-id pub-id-type="pmid">27884742</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantelli</surname><given-names>B. A. M.</given-names></name><name><surname>Bitencourt</surname><given-names>T. A.</given-names></name><name><surname>Komoto</surname><given-names>T. T.</given-names></name><name><surname>Beleboni</surname><given-names>R. O.</given-names></name><name><surname>Marins</surname><given-names>M.</given-names></name><name><surname>Fachin</surname><given-names>A. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Caffeic acid and licochalcone A interfere with the glyoxylate cycle of <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Biomed. Pharmacother.</italic></source>
<volume>96</volume>
<fpage>1389</fpage>&#x02013;<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.11.051</pub-id>
<?supplied-pmid 29174577?><pub-id pub-id-type="pmid">29174577</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Pinto</surname><given-names>E.</given-names></name><name><surname>Goncalves</surname><given-names>M. J.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Antifungal activity of <italic>Juniperus</italic> essential oils against dermatophyte, <italic>Aspergillus</italic> and <italic>Candida</italic> strains.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>100</volume>
<fpage>1333</fpage>&#x02013;<lpage>1338</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.2006.02862.x</pub-id>
<?supplied-pmid 16696681?><pub-id pub-id-type="pmid">16696681</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervelatti</surname><given-names>E. P.</given-names></name><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Ferreira-Nozawa</surname><given-names>M. S.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Molecular cloning and characterization of a novel ABC transporter gene in the human pathogen <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>44</volume>
<fpage>141</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1080/13693780500220449</pub-id>
<?supplied-pmid 16519017?><pub-id pub-id-type="pmid">16519017</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Tatu</surname><given-names>U.</given-names></name></person-group> (<year>2017</year>). <article-title>Heat shock protein 90 localizes to the surface and augments virulence factors of <italic>Cryptococcus neoformans</italic>.</article-title>
<source><italic>PLoS Negl. Trop. Dis.</italic></source>
<volume>11</volume>:<issue>e0005836</issue>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005836</pub-id>
<?supplied-pmid 28783748?><pub-id pub-id-type="pmid">28783748</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheah</surname><given-names>H. L.</given-names></name><name><surname>Lim</surname><given-names>V.</given-names></name><name><surname>Sandai</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibitors of the glyoxylate cycle enzyme ICL1 in <italic>Candida albicans</italic> for potential use as antifungal agents.</article-title>
<source><italic>PLoS One</italic></source>
<volume>9</volume>:<issue>e95951</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0095951</pub-id>
<?supplied-pmid 24781056?><pub-id pub-id-type="pmid">24781056</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemons</surname><given-names>K. V.</given-names></name><name><surname>Stevens</surname><given-names>D. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Efficacy of nikkomycin Z against experimental pulmonary blastomycosis.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>41</volume>
<fpage>2026</fpage>&#x02013;<lpage>2028</lpage>. <?supplied-pmid 9303408?><pub-id pub-id-type="pmid">9303408</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>L. M.</given-names></name><name><surname>Aquino-Ferreira</surname><given-names>R.</given-names></name><name><surname>Maffei</surname><given-names>C. M. L.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>In vitro</italic> antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>62</volume>
<fpage>758</fpage>&#x02013;<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn245</pub-id>
<?supplied-pmid 18552341?><pub-id pub-id-type="pmid">18552341</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J. J.</given-names></name><name><surname>Mylonakis</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Efflux in fungi: la piece de resistance.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>5</volume>:<issue>e1000486</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000486</pub-id>
<?supplied-pmid 19557154?><pub-id pub-id-type="pmid">19557154</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>B. J.</given-names></name><name><surname>Bufalo</surname><given-names>M. C.</given-names></name><name><surname>Golim Mde</surname><given-names>A.</given-names></name><name><surname>Bankova</surname><given-names>V.</given-names></name><name><surname>Sforcin</surname><given-names>J. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Cinnamic acid is partially involved in propolis immunomodulatory action on human monocytes.</article-title>
<source><italic>Evid. Based Complement. Alternat. Med.</italic></source>
<volume>2013</volume>:<issue>109864</issue>. <pub-id pub-id-type="doi">10.1155/2013/109864</pub-id>
<?supplied-pmid 23762102?><pub-id pub-id-type="pmid">23762102</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Orlandi</surname><given-names>C. B.</given-names></name><name><surname>Sardi</surname><given-names>J. C.</given-names></name><name><surname>Santos</surname><given-names>C. T.</given-names></name><name><surname>Fusco-Almeida</surname><given-names>A. M.</given-names></name><name><surname>Mendes-Giannini</surname><given-names>M. J.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>In vitro</italic> characterization of <italic>Trichophyton rubrum</italic> and <italic>T. mentagrophytes</italic> biofilms.</article-title>
<source><italic>Biofouling</italic></source>
<volume>30</volume>
<fpage>719</fpage>&#x02013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2014.919282</pub-id>
<?supplied-pmid 24856309?><pub-id pub-id-type="pmid">24856309</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L. E.</given-names></name></person-group> (<year>2008</year>). <article-title>The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>6</volume>
<fpage>187</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1835</pub-id>
<?supplied-pmid 18246082?><pub-id pub-id-type="pmid">18246082</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Hsp90 orchestrates stress response signaling governing fungal drug resistance.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>5</volume>:<issue>e1000471</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000471</pub-id>
<?supplied-pmid 19714223?><pub-id pub-id-type="pmid">19714223</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L. E.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi.</article-title>
<source><italic>Science</italic></source>
<volume>309</volume>
<fpage>2185</fpage>&#x02013;<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.1126/science.1118370</pub-id>
<?supplied-pmid 16195452?><pub-id pub-id-type="pmid">16195452</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L. E.</given-names></name><name><surname>Sanglard</surname><given-names>D.</given-names></name><name><surname>Howard</surname><given-names>S. J.</given-names></name><name><surname>Rogers</surname><given-names>P. D.</given-names></name><name><surname>Perlin</surname><given-names>D. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of antifungal drug resistance.</article-title>
<source><italic>Cold Spring Harb. Perspect. Med.</italic></source>
<volume>5</volume>:<issue>a019752</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a019752</pub-id>
<?supplied-pmid 25384768?><pub-id pub-id-type="pmid">25384768</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Campos</surname><given-names>M. P.</given-names></name><name><surname>Cechinel</surname><given-names>V.</given-names></name><name><surname>Da Silva</surname><given-names>R. Z.</given-names></name><name><surname>Yunes</surname><given-names>R. A.</given-names></name><name><surname>Zacchino</surname><given-names>S.</given-names></name><name><surname>Juarez</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Evaluation of antifungal activity of <italic>Piper solmsianum</italic> C. DC. var. <italic>solmsianum</italic> (Piperaceae).</article-title>
<source><italic>Biol. Pharm. Bull.</italic></source>
<volume>28</volume>
<fpage>1527</fpage>&#x02013;<lpage>1530</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.28.1527</pub-id>
<?supplied-pmid 16079508?><pub-id pub-id-type="pmid">16079508</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Maio</surname><given-names>A.</given-names></name><name><surname>Santoro</surname><given-names>M. G.</given-names></name><name><surname>Tanguay</surname><given-names>R. M.</given-names></name><name><surname>Hightower</surname><given-names>L. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Ferruccio Ritossa&#x02019;s scientific legacy 50 years after his discovery of the heat shock response: a new view of biology, a new society, and a new journal.</article-title>
<source><italic>Cell Stress Chaperones</italic></source>
<volume>17</volume>
<fpage>139</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1007/s12192-012-0320-z</pub-id>
<?supplied-pmid 22252402?><pub-id pub-id-type="pmid">22252402</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Melo</surname><given-names>J. O.</given-names></name><name><surname>Bitencourt</surname><given-names>T. A.</given-names></name><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Cruz</surname><given-names>E. M.</given-names></name><name><surname>De Jesus</surname><given-names>H. C.</given-names></name><name><surname>Alves</surname><given-names>P. B.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Antidermatophytic and antileishmanial activities of essential oils from <italic>Lippia gracilis</italic> Schauer genotypes.</article-title>
<source><italic>Acta Trop.</italic></source>
<volume>128</volume>
<fpage>110</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2013.06.024</pub-id>
<?supplied-pmid 23850505?><pub-id pub-id-type="pmid">23850505</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira Lima</surname><given-names>M. I.</given-names></name><name><surname>Araujo de Medeiros</surname><given-names>A. C.</given-names></name><name><surname>Souza Silva</surname><given-names>K. V.</given-names></name><name><surname>Cardoso</surname><given-names>G. N.</given-names></name><name><surname>De Oliveira Lima</surname><given-names>E.</given-names></name><name><surname>De Oliveira Pereira</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>J. Mycol. Med.</italic></source>
<volume>27</volume>
<fpage>195</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.mycmed.2017.01.011</pub-id>
<?supplied-pmid 28189377?><pub-id pub-id-type="pmid">28189377</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delarze</surname><given-names>E.</given-names></name><name><surname>Sanglard</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.</article-title>
<source><italic>Drug Resist. Updat.</italic></source>
<volume>23</volume>
<fpage>12</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.drup.2015.10.001</pub-id>
<?supplied-pmid 26690338?><pub-id pub-id-type="pmid">26690338</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>S. W.</given-names></name><name><surname>Ansari</surname><given-names>S.</given-names></name><name><surname>Ilkit</surname><given-names>M.</given-names></name><name><surname>Rafati</surname><given-names>H.</given-names></name><name><surname>Hedayati</surname><given-names>M. T.</given-names></name><name><surname>Taghizadeh-Armaki</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title><italic>In vitro</italic> antifungal susceptibility profiles of 12 antifungal drugs against 55 <italic>Trichophyton schoenleinii</italic> isolates from tinea capitis favosa patients in Iran, Turkey, and China.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e01753-16</issue>. <?supplied-pmid 27956429?><pub-id pub-id-type="pmid">27956429</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>R.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Leng</surname><given-names>W.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>Q.</given-names></name></person-group> (<year>2009</year>). <article-title>Transcriptional profiles of <italic>Trichophyton rubrum</italic> in response to itraconazole.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>47</volume>
<fpage>237</fpage>&#x02013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1080/13693780802227308</pub-id>
<?supplied-pmid 18663659?><pub-id pub-id-type="pmid">18663659</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudiuk</surname><given-names>C.</given-names></name><name><surname>Macedo</surname><given-names>D.</given-names></name><name><surname>Leonardelli</surname><given-names>F.</given-names></name><name><surname>Theill</surname><given-names>L.</given-names></name><name><surname>Cabeza</surname><given-names>M. S.</given-names></name><name><surname>Gamarra</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Molecular confirmation of the relationship between <italic>Candida guilliermondii</italic> Fks1p naturally occurring amino acid substitutions and its intrinsic reduced echinocandin susceptibility.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e02644-16</issue>. <pub-id pub-id-type="doi">10.1128/AAC.02644-16</pub-id>
<?supplied-pmid 28242659?><pub-id pub-id-type="pmid">28242659</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Awady</surname><given-names>R.</given-names></name><name><surname>Saleh</surname><given-names>E.</given-names></name><name><surname>Hashim</surname><given-names>A.</given-names></name><name><surname>Soliman</surname><given-names>N.</given-names></name><name><surname>Dallah</surname><given-names>A.</given-names></name><name><surname>Elrasheed</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy.</article-title>
<source><italic>Front. Pharmacol.</italic></source>
<volume>7</volume>:<issue>535</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00535</pub-id>
<?supplied-pmid 28119610?><pub-id pub-id-type="pmid">28119610</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Contel</surname><given-names>E. P.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Effect of sub-MICs of antimycotics on expression of intracellular esterase of <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>39</volume>
<fpage>129</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1080/mmy.39.1.129.133</pub-id>
<?supplied-pmid 11270400?><pub-id pub-id-type="pmid">11270400</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Ferreira-Nozawa</surname><given-names>M. S.</given-names></name><name><surname>Maccheroni</surname><given-names>W.</given-names><suffix>Jr.</suffix></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>55</volume>
<fpage>1093</fpage>&#x02013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.46522-0</pub-id>
<?supplied-pmid 16849730?><pub-id pub-id-type="pmid">16849730</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Maffei</surname><given-names>C. M. L.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>1996</year>). <article-title><italic>In vitro</italic> susceptibility of <italic>Trichophyton rubrum</italic> isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>135</volume>
<fpage>141</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1007/BF00632334</pub-id>
<?supplied-pmid 9066154?><pub-id pub-id-type="pmid">9066154</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanning</surname><given-names>S.</given-names></name><name><surname>Mitchell</surname><given-names>A. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Fungal biofilms.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>8</volume>:<issue>e1002585</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002585</pub-id>
<?supplied-pmid 22496639?><pub-id pub-id-type="pmid">22496639</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favre</surname><given-names>B.</given-names></name><name><surname>Ryder</surname><given-names>N. S.</given-names></name></person-group> (<year>1996</year>). <article-title>Characterization of squalene epoxidase activity from the dermatophyte <italic>Trichophyton rubrum</italic> and its inhibition by terbinafine and other antimycotic agents.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>40</volume>
<fpage>443</fpage>&#x02013;<lpage>447</lpage>. <?supplied-pmid 8834895?><pub-id pub-id-type="pmid">8834895</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Leem</surname><given-names>Y. E.</given-names></name><name><surname>Levin</surname><given-names>H. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Transposon integration enhances expression of stress response genes.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>41</volume>
<fpage>775</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1185</pub-id>
<?supplied-pmid 23193295?><pub-id pub-id-type="pmid">23193295</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Nozawa</surname><given-names>M. S.</given-names></name><name><surname>Silveira</surname><given-names>H. C. S.</given-names></name><name><surname>Ono</surname><given-names>C. J.</given-names></name><name><surname>Fachin</surname><given-names>A. L.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The pH signaling transcription factor PacC mediates the growth of <italic>Trichophyton rubrum</italic> on human nail <italic>in vitro</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>44</volume>
<fpage>641</fpage>&#x02013;<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1080/13693780600876553</pub-id>
<?supplied-pmid 17071558?><pub-id pub-id-type="pmid">17071558</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>A. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Chaperone-mediated protein folding.</article-title>
<source><italic>Physiol. Rev.</italic></source>
<volume>79</volume>
<fpage>425</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.1999.79.2.425</pub-id>
<?supplied-pmid 10221986?><pub-id pub-id-type="pmid">10221986</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friesen</surname><given-names>H.</given-names></name><name><surname>Lunz</surname><given-names>R.</given-names></name><name><surname>Doyle</surname><given-names>S.</given-names></name><name><surname>Segall</surname><given-names>J.</given-names></name></person-group> (<year>1994</year>). <article-title>Mutation of the SPS1-encoded protein kinase of <italic>Saccharomyces cerevisiae</italic> leads to defects in transcription and morphology during spore formation.</article-title>
<source><italic>Genes Dev.</italic></source>
<volume>8</volume>
<fpage>2162</fpage>&#x02013;<lpage>2175</lpage>. <pub-id pub-id-type="doi">10.1101/gad.8.18.2162</pub-id>
<?supplied-pmid 7958886?><pub-id pub-id-type="pmid">7958886</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadzalski</surname><given-names>M.</given-names></name><name><surname>Ciesielska</surname><given-names>A.</given-names></name><name><surname>Staczek</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Bioinformatic survey of ABC transporters in dermatophytes.</article-title>
<source><italic>Gene</italic></source>
<volume>576</volume>
<fpage>466</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2015.10.064</pub-id>
<?supplied-pmid 26524502?><pub-id pub-id-type="pmid">26524502</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garaizar</surname><given-names>J.</given-names></name><name><surname>Brena</surname><given-names>S.</given-names></name><name><surname>Bikandi</surname><given-names>J.</given-names></name><name><surname>Rementeria</surname><given-names>A.</given-names></name><name><surname>Ponton</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of <italic>Candida albicans</italic>.</article-title>
<source><italic>FEMS Yeast Res.</italic></source>
<volume>6</volume>
<fpage>987</fpage>&#x02013;<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1111/j.1567-1364.2006.00108.x</pub-id>
<?supplied-pmid 17042748?><pub-id pub-id-type="pmid">17042748</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Romero</surname><given-names>M. T.</given-names></name><name><surname>Arenas</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>New insights into genes, immunity, and the occurrence of dermatophytosis.</article-title>
<source><italic>J. Invest. Dermatol.</italic></source>
<volume>135</volume>
<fpage>655</fpage>&#x02013;<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2014.498</pub-id>
<?supplied-pmid 25666672?><pub-id pub-id-type="pmid">25666672</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garvey</surname><given-names>E. P.</given-names></name><name><surname>Hoekstra</surname><given-names>W. J.</given-names></name><name><surname>Moore</surname><given-names>W. R.</given-names></name><name><surname>Schotzinger</surname><given-names>R. J.</given-names></name><name><surname>Long</surname><given-names>L.</given-names></name><name><surname>Ghannoum</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>59</volume>
<fpage>1992</fpage>&#x02013;<lpage>1997</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.04902-14</pub-id>
<?supplied-pmid 25605358?><pub-id pub-id-type="pmid">25605358</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghelardi</surname><given-names>E.</given-names></name><name><surname>Celandroni</surname><given-names>F.</given-names></name><name><surname>Gueye</surname><given-names>S. A.</given-names></name><name><surname>Salvetti</surname><given-names>S.</given-names></name><name><surname>Senesi</surname><given-names>S.</given-names></name><name><surname>Bulgheroni</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Potential of ergosterol synthesis inhibitors to cause resistance or cross-resistance in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>58</volume>
<fpage>2825</fpage>&#x02013;<lpage>2829</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02382-13</pub-id>
<?supplied-pmid 24614379?><pub-id pub-id-type="pmid">24614379</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glavinas</surname><given-names>H.</given-names></name><name><surname>Krajcsi</surname><given-names>P.</given-names></name><name><surname>Cserepes</surname><given-names>J.</given-names></name><name><surname>Sarkadi</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>The role of ABC transporters in drug resistance, metabolism and toxicity.</article-title>
<source><italic>Curr. Drug Deliv.</italic></source>
<volume>1</volume>
<fpage>27</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2174/1567201043480036</pub-id><pub-id pub-id-type="pmid">16305368</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title><italic>Candida albicans</italic> heat shock proteins and Hsps-associated signaling pathways as potential antifungal targets.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>7</volume>:<issue>520</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00520</pub-id>
<?supplied-pmid 29312897?><pub-id pub-id-type="pmid">29312897</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graminha</surname><given-names>M. A. S.</given-names></name><name><surname>Rocha</surname><given-names>E. M. F.</given-names></name><name><surname>Prade</surname><given-names>R. A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Terbinafine resistance mediated by salicylate 1-monooxygenase in <italic>Aspergillus nidulans</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>48</volume>
<fpage>3530</fpage>&#x02013;<lpage>3535</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.48.9.3530-3535.2004</pub-id>
<?supplied-pmid 15328121?><pub-id pub-id-type="pmid">15328121</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A. K.</given-names></name><name><surname>Daigle</surname><given-names>D.</given-names></name><name><surname>Carviel</surname><given-names>J. L.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of biofilms in onychomycosis.</article-title>
<source><italic>J. Am. Acad. Dermatol.</italic></source>
<volume>74</volume>
<fpage>1241</fpage>&#x02013;<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2016.01.008</pub-id>
<?supplied-pmid 27012826?><pub-id pub-id-type="pmid">27012826</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A. K.</given-names></name><name><surname>Kohli</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>In vitro</italic> susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and <italic>in vitro</italic> evaluation of combination antifungal activity.</article-title>
<source><italic>Br. J. Dermatol.</italic></source>
<volume>149</volume>
<fpage>296</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2133.2003.05418.x</pub-id>
<?supplied-pmid 12932235?><pub-id pub-id-type="pmid">12932235</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>C.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Ramachandran</surname><given-names>V. G.</given-names></name><name><surname>Saha</surname><given-names>R.</given-names></name><name><surname>Bhattacharya</surname><given-names>S. N.</given-names></name><name><surname>Dar</surname><given-names>S. A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Possible role of trichophytin antigen in inducing impaired immunological clearance of fungus in onychomycosis.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>181</volume>
<fpage>247</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-015-9973-3</pub-id>
<?supplied-pmid 26614362?><pub-id pub-id-type="pmid">26614362</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>N.</given-names></name><name><surname>Ras</surname><given-names>J.</given-names></name><name><surname>Reijnders</surname><given-names>W. N.</given-names></name><name><surname>Van Spanning</surname><given-names>R. J.</given-names></name><name><surname>Stouthamer</surname><given-names>A. H.</given-names></name></person-group> (<year>1996</year>). <article-title>S-formylglutathione hydrolase of <italic>Paracoccus denitrificans</italic> is homologous to human esterase D: a universal pathway for formaldehyde detoxification?</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>178</volume>
<fpage>6296</fpage>&#x02013;<lpage>6299</lpage>. <pub-id pub-id-type="doi">10.1128/jb.178.21.6296-6299.1996</pub-id><pub-id pub-id-type="pmid">8892832</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hau</surname><given-names>C. S.</given-names></name><name><surname>Tada</surname><given-names>Y.</given-names></name><name><surname>Kanda</surname><given-names>N.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Immunoresponses in dermatomycoses.</article-title>
<source><italic>J. Dermatol.</italic></source>
<volume>42</volume>
<fpage>236</fpage>&#x02013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1111/1346-8138.12718</pub-id>
<?supplied-pmid 25736316?><pub-id pub-id-type="pmid">25736316</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havlickova</surname><given-names>B.</given-names></name><name><surname>Czaika</surname><given-names>V. A.</given-names></name><name><surname>Friedrich</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Epidemiological trends in skin mycoses worldwide.</article-title>
<source><italic>Mycoses</italic></source>
<volume>51(Suppl. 4)</volume>
<fpage>2</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0507.2008.01606.x</pub-id>
<?supplied-pmid 18783559?><pub-id pub-id-type="pmid">18783559</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>B. M.</given-names></name><name><surname>Anderson</surname><given-names>M. A.</given-names></name><name><surname>Traven</surname><given-names>A.</given-names></name><name><surname>Van Der Weerden</surname><given-names>N. L.</given-names></name><name><surname>Bleackley</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins.</article-title>
<source><italic>Cell. Mol. Life Sci.</italic></source>
<volume>71</volume>
<fpage>2651</fpage>&#x02013;<lpage>2666</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-014-1573-8</pub-id>
<?supplied-pmid 24526056?><pub-id pub-id-type="pmid">24526056</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinen</surname><given-names>M. P.</given-names></name><name><surname>Cambier</surname><given-names>L.</given-names></name><name><surname>Fievez</surname><given-names>L.</given-names></name><name><surname>Mignon</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Are Th17 cells playing a role in immunity to dermatophytosis?</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>182</volume>
<fpage>251</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-016-0093-5</pub-id>
<?supplied-pmid 27878642?><pub-id pub-id-type="pmid">27878642</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>A. R.</given-names></name><name><surname>Cardno</surname><given-names>T. S.</given-names></name><name><surname>Strouse</surname><given-names>J. J.</given-names></name><name><surname>Ivnitski-Steele</surname><given-names>I.</given-names></name><name><surname>Keniya</surname><given-names>M. V.</given-names></name><name><surname>Lackovic</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Targeting efflux pumps to overcome antifungal drug resistance.</article-title>
<source><italic>Future Med. Chem.</italic></source>
<volume>8</volume>
<fpage>1485</fpage>&#x02013;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.4155/fmc-2016-0050</pub-id>
<?supplied-pmid 27463566?><pub-id pub-id-type="pmid">27463566</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>A. R.</given-names></name><name><surname>Keniya</surname><given-names>M. V.</given-names></name><name><surname>Ivnitski-Steele</surname><given-names>I.</given-names></name><name><surname>Monk</surname><given-names>B. C.</given-names></name><name><surname>Lamping</surname><given-names>E.</given-names></name><name><surname>Sklar</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of <italic>Candida albicans</italic> and <italic>Candida glabrata</italic> clinical isolates.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>56</volume>
<fpage>1508</fpage>&#x02013;<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.05706-11</pub-id>
<?supplied-pmid 22203607?><pub-id pub-id-type="pmid">22203607</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Housman</surname><given-names>G.</given-names></name><name><surname>Byler</surname><given-names>S.</given-names></name><name><surname>Heerboth</surname><given-names>S.</given-names></name><name><surname>Lapinska</surname><given-names>K.</given-names></name><name><surname>Longacre</surname><given-names>M.</given-names></name><name><surname>Snyder</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Drug resistance in cancer: an overview.</article-title>
<source><italic>Cancers</italic></source>
<volume>6</volume>
<fpage>1769</fpage>&#x02013;<lpage>1792</lpage>. <pub-id pub-id-type="doi">10.3390/cancers6031769</pub-id>
<?supplied-pmid 25198391?><pub-id pub-id-type="pmid">25198391</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Su</surname><given-names>Y. E.</given-names></name><name><surname>Qu</surname><given-names>L. J.</given-names></name><name><surname>Deng</surname><given-names>X. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Arabidopsis atypical kinases ABC1K1 and ABC1K3 act oppositely to cope with photodamage under red light.</article-title>
<source><italic>Mol. Plant</italic></source>
<volume>8</volume>
<fpage>1122</fpage>&#x02013;<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1016/j.molp.2015.04.003</pub-id>
<?supplied-pmid 25882344?><pub-id pub-id-type="pmid">25882344</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hube</surname><given-names>B.</given-names></name><name><surname>Hay</surname><given-names>R.</given-names></name><name><surname>Brasch</surname><given-names>J.</given-names></name><name><surname>Veraldi</surname><given-names>S.</given-names></name><name><surname>Schaller</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Dermatomycoses and inflammation: the adaptive balance between growth, damage, and survival.</article-title>
<source><italic>J. Mycol. Med.</italic></source>
<volume>25</volume>
<fpage>e44</fpage>&#x02013;<lpage>e58</lpage>. <pub-id pub-id-type="doi">10.1016/j.mycmed.2014.11.002</pub-id>
<?supplied-pmid 25662199?><pub-id pub-id-type="pmid">25662199</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>A.</given-names></name><name><surname>Batovska</surname><given-names>D.</given-names></name><name><surname>Engi</surname><given-names>H.</given-names></name><name><surname>Parushev</surname><given-names>S.</given-names></name><name><surname>Ocsovszki</surname><given-names>I.</given-names></name><name><surname>Kostova</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>MDR-reversal activity of chalcones.</article-title>
<source><italic>In Vivo</italic></source>
<volume>22</volume>
<fpage>379</fpage>&#x02013;<lpage>384</lpage>.<pub-id pub-id-type="pmid">18610751</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. R.</given-names></name><name><surname>Peres</surname><given-names>N. T.</given-names></name><name><surname>Martins</surname><given-names>M. P.</given-names></name><name><surname>Lang</surname><given-names>E. A.</given-names></name><name><surname>Sanches</surname><given-names>P. R.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Heat shock protein 90 (Hsp90) as a molecular target for the development of novel drugs against the dermatophyte <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>1241</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.01241</pub-id>
<?supplied-pmid 26617583?><pub-id pub-id-type="pmid">26617583</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>U. S.</given-names></name><name><surname>Levin</surname><given-names>D. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signalling pathway.</article-title>
<source><italic>Mol. Microbiol.</italic></source>
<volume>34</volume>
<fpage>1049</fpage>&#x02013;<lpage>1057</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01667.x</pub-id><pub-id pub-id-type="pmid">10594829</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanafani</surname><given-names>Z. A.</given-names></name><name><surname>Perfect</surname><given-names>J. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.</article-title>
<source><italic>Clin. Infect. Dis.</italic></source>
<volume>46</volume>
<fpage>120</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1086/524071</pub-id>
<?supplied-pmid 18171227?><pub-id pub-id-type="pmid">18171227</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kano</surname><given-names>R.</given-names></name><name><surname>Hsiao</surname><given-names>Y. H.</given-names></name><name><surname>Han</surname><given-names>H. S.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Hasegawa</surname><given-names>A.</given-names></name><name><surname>Kamata</surname><given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Resistance mechanism in a terbinafine-resistant strain of <italic>Microsporum canis</italic>.</article-title>
<source><italic>Mycopathologia</italic></source>
<pub-id pub-id-type="doi">10.1007/s11046-018-0242-0</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 29340910?><pub-id pub-id-type="pmid">29340910</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>T.</given-names></name><name><surname>Kashiwagi</surname><given-names>E.</given-names></name><name><surname>Ide</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>Y. C.</given-names></name><name><surname>Miyamoto</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.</article-title>
<source><italic>Oncotarget</italic></source>
<volume>6</volume>
<fpage>1582</fpage>&#x02013;<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.2750</pub-id>
<?supplied-pmid 25638160?><pub-id pub-id-type="pmid">25638160</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keukens</surname><given-names>E. A.</given-names></name><name><surname>De Vrije</surname><given-names>T.</given-names></name><name><surname>Van Den Boom</surname><given-names>C.</given-names></name><name><surname>De Waard</surname><given-names>P.</given-names></name><name><surname>Plasman</surname><given-names>H. H.</given-names></name><name><surname>Thiel</surname><given-names>F.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Molecular basis of glycoalkaloid induced membrane disruption.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1240</volume>
<fpage>216</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2736(95)00186-7</pub-id>
<?supplied-pmid 8541293?><pub-id pub-id-type="pmid">8541293</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>J. R.</given-names></name><name><surname>Hube</surname><given-names>B.</given-names></name><name><surname>Puccia</surname><given-names>R.</given-names></name><name><surname>Casadevall</surname><given-names>A.</given-names></name><name><surname>Perfect</surname><given-names>J. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Fungi that infect humans.</article-title>
<source><italic>Microbiol. Spectr.</italic></source>
<volume>5</volume>:<issue>FUNK-0014-2016</issue>. <pub-id pub-id-type="doi">10.1128/microbiolspec.FUNK-0014-2016</pub-id>
<?supplied-pmid 28597822?><pub-id pub-id-type="pmid">28597822</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komoto</surname><given-names>T. T.</given-names></name><name><surname>Bitencourt</surname><given-names>T. A.</given-names></name><name><surname>Silva</surname><given-names>G.</given-names></name><name><surname>Beleboni</surname><given-names>R. O.</given-names></name><name><surname>Marins</surname><given-names>M.</given-names></name><name><surname>Fachin</surname><given-names>A. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Gene expression response of <italic>Trichophyton rubrum</italic> during coculture on keratinocytes exposed to antifungal agents.</article-title>
<source><italic>Evid. Based Complement. Alternat. Med.</italic></source>
<volume>2015</volume>:<issue>180535</issue>. <pub-id pub-id-type="doi">10.1155/2015/180535</pub-id>
<?supplied-pmid 26257814?><pub-id pub-id-type="pmid">26257814</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koselny</surname><given-names>K.</given-names></name><name><surname>Green</surname><given-names>J.</given-names></name><name><surname>Didone</surname><given-names>L.</given-names></name><name><surname>Halterman</surname><given-names>J. P.</given-names></name><name><surname>Fothergill</surname><given-names>A. W.</given-names></name><name><surname>Wiederhold</surname><given-names>N. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The celecoxib derivative AR-12 has broad-spectrum antifungal activity <italic>in vitro</italic> and improves the activity of fluconazole in a murine model of cryptococcosis.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>60</volume>
<fpage>7115</fpage>&#x02013;<lpage>7127</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01061-16</pub-id>
<?supplied-pmid 27645246?><pub-id pub-id-type="pmid">27645246</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurdelas</surname><given-names>R. R.</given-names></name><name><surname>Lima</surname><given-names>B.</given-names></name><name><surname>Tapia</surname><given-names>A.</given-names></name><name><surname>Feresin</surname><given-names>G. E.</given-names></name><name><surname>Gonzalez Sierra</surname><given-names>M.</given-names></name><name><surname>Rodriguez</surname><given-names>M. V.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Antifungal activity of extracts and prenylated coumarins isolated from <italic>Baccharis darwinii</italic> Hook &#x00026; Arn. (Asteraceae).</article-title>
<source><italic>Molecules</italic></source>
<volume>15</volume>
<fpage>4898</fpage>&#x02013;<lpage>4907</lpage>. <pub-id pub-id-type="doi">10.3390/molecules15074898</pub-id>
<?supplied-pmid 20657398?><pub-id pub-id-type="pmid">20657398</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushwaha</surname><given-names>A. S.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Shivakumar</surname><given-names>H. N.</given-names></name><name><surname>Rappleye</surname><given-names>C.</given-names></name><name><surname>Zukiwski</surname><given-names>A.</given-names></name><name><surname>Proniuk</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Trans-ungual delivery of AR-12, a novel antifungal drug.</article-title>
<source><italic>AAPS PharmSciTech</italic></source>
<volume>18</volume>
<fpage>2702</fpage>&#x02013;<lpage>2705</lpage>. <pub-id pub-id-type="doi">10.1208/s12249-017-0752-y</pub-id>
<?supplied-pmid 28289970?><pub-id pub-id-type="pmid">28289970</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacka</surname><given-names>I.</given-names></name><name><surname>Konieczny</surname><given-names>M. T.</given-names></name><name><surname>Bulakowska</surname><given-names>A.</given-names></name><name><surname>Kodedova</surname><given-names>M.</given-names></name><name><surname>Gaskova</surname><given-names>D.</given-names></name><name><surname>Maurya</surname><given-names>I. K.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Chemosensitization of multidrug resistant <italic>Candida albicans</italic> by the oxathiolone fused chalcone derivatives.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>783</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.00783</pub-id>
<?supplied-pmid 26300857?><pub-id pub-id-type="pmid">26300857</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lackner</surname><given-names>M.</given-names></name><name><surname>Tscherner</surname><given-names>M.</given-names></name><name><surname>Schaller</surname><given-names>M.</given-names></name><name><surname>Kuchler</surname><given-names>K.</given-names></name><name><surname>Mair</surname><given-names>C.</given-names></name><name><surname>Sartori</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Positions and numbers of FKS mutations in <italic>Candida albicans</italic> selectively influence <italic>in vitro</italic> and <italic>in vivo</italic> susceptibilities to echinocandin treatment.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>58</volume>
<fpage>3626</fpage>&#x02013;<lpage>3635</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00123-14</pub-id>
<?supplied-pmid 24733467?><pub-id pub-id-type="pmid">24733467</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamoth</surname><given-names>F.</given-names></name><name><surname>Juvvadi</surname><given-names>P. R.</given-names></name><name><surname>Fortwendel</surname><given-names>J. R.</given-names></name><name><surname>Steinbach</surname><given-names>W. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Heat shock protein 90 is required for conidiation and cell wall integrity in <italic>Aspergillus fumigatus</italic>.</article-title>
<source><italic>Eukaryot. Cell</italic></source>
<volume>11</volume>
<fpage>1324</fpage>&#x02013;<lpage>1332</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00032-12</pub-id>
<?supplied-pmid 22822234?><pub-id pub-id-type="pmid">22822234</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamoth</surname><given-names>F.</given-names></name><name><surname>Juvvadi</surname><given-names>P. R.</given-names></name><name><surname>Steinbach</surname><given-names>W. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Heat shock protein 90 (Hsp90): a novel antifungal target against <italic>Aspergillus fumigatus</italic>.</article-title>
<source><italic>Crit. Rev. Microbiol.</italic></source>
<volume>42</volume>
<fpage>310</fpage>&#x02013;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.3109/1040841X.2014.947239</pub-id>
<?supplied-pmid 25243616?><pub-id pub-id-type="pmid">25243616</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanternier</surname><given-names>F.</given-names></name><name><surname>Pathan</surname><given-names>S.</given-names></name><name><surname>Vincent</surname><given-names>Q. B.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Cypowyj</surname><given-names>S.</given-names></name><name><surname>Prando</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Deep dermatophytosis and inherited CARD9 deficiency.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>369</volume>
<fpage>1704</fpage>&#x02013;<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1208487</pub-id>
<?supplied-pmid 24131138?><pub-id pub-id-type="pmid">24131138</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>M. D.</given-names></name><name><surname>Budge</surname><given-names>S.</given-names></name><name><surname>Walker</surname><given-names>L.</given-names></name><name><surname>Munro</surname><given-names>C.</given-names></name><name><surname>Cowen</surname><given-names>L. E.</given-names></name><name><surname>Brown</surname><given-names>A. J.</given-names></name></person-group> (<year>2012a</year>). <article-title>Hsp90 orchestrates transcriptional regulation by Hsf1 and cell wall remodelling by MAPK signalling during thermal adaptation in a pathogenic yeast.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>8</volume>:<issue>e1003069</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003069</pub-id>
<?supplied-pmid 23300438?><pub-id pub-id-type="pmid">23300438</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>M. D.</given-names></name><name><surname>Klipp</surname><given-names>E.</given-names></name><name><surname>Cowen</surname><given-names>L. E.</given-names></name><name><surname>Brown</surname><given-names>A. J.</given-names></name></person-group> (<year>2012b</year>). <article-title>Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>10</volume>
<fpage>693</fpage>&#x02013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2875</pub-id>
<?supplied-pmid 22976491?><pub-id pub-id-type="pmid">22976491</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>D. G.</given-names></name></person-group> (<year>2014</year>). <article-title>An antifungal mechanism of curcumin lies in membrane-targeted action within <italic>Candida albicans</italic>.</article-title>
<source><italic>IUBMB Life</italic></source>
<volume>66</volume>
<fpage>780</fpage>&#x02013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1326</pub-id>
<?supplied-pmid 25380239?><pub-id pub-id-type="pmid">25380239</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>An</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole.</article-title>
<source><italic>Am. J. Transl. Res.</italic></source>
<volume>7</volume>
<fpage>2589</fpage>&#x02013;<lpage>2602</lpage>. <?supplied-pmid 26885259?><pub-id pub-id-type="pmid">26885259</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Fatty acid synthase inhibitors from <italic>Geum japonicum</italic> Thunb. var. <italic>chinense</italic>.</article-title>
<source><italic>Chem. Biodivers.</italic></source>
<volume>6</volume>
<fpage>402</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1002/cbdv.200700462</pub-id>
<?supplied-pmid 19319862?><pub-id pub-id-type="pmid">19319862</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>May</surname><given-names>G. S.</given-names></name><name><surname>Lionakis</surname><given-names>M. S.</given-names></name><name><surname>Lewis</surname><given-names>R. E.</given-names></name><name><surname>Kontoyiannis</surname><given-names>D. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Extra copies of the <italic>Aspergillus fumigatus</italic> squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in <italic>A. fumigatus</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>48</volume>
<fpage>2490</fpage>&#x02013;<lpage>2496</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.48.7.2490-2496.2004</pub-id>
<?supplied-pmid 15215099?><pub-id pub-id-type="pmid">15215099</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>S. R.</given-names></name><name><surname>Fothergill</surname><given-names>A. W.</given-names></name><name><surname>Iqbal</surname><given-names>N.</given-names></name><name><surname>Bolden</surname><given-names>C. B.</given-names></name><name><surname>Grossman</surname><given-names>N. T.</given-names></name><name><surname>Garvey</surname><given-names>E. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent <italic>in vitro</italic> activity against <italic>Cryptococcus neoformans</italic> and <italic>Cryptococcus gattii</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>60</volume>
<fpage>2528</fpage>&#x02013;<lpage>2531</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02770-15</pub-id>
<?supplied-pmid 26787697?><pub-id pub-id-type="pmid">26787697</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>M. C.</given-names></name><name><surname>Fink</surname><given-names>G. R.</given-names></name></person-group> (<year>2001</year>). <article-title>The glyoxylate cycle is required for fungal virulence.</article-title>
<source><italic>Nature</italic></source>
<volume>412</volume>
<fpage>83</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1038/35083594</pub-id>
<?supplied-pmid 11452311?><pub-id pub-id-type="pmid">11452311</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>T.</given-names></name><name><surname>Leibundgut</surname><given-names>M.</given-names></name><name><surname>Boehringer</surname><given-names>D.</given-names></name><name><surname>Ban</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Structure and function of eukaryotic fatty acid synthases.</article-title>
<source><italic>Q. Rev. Biophys.</italic></source>
<volume>43</volume>
<fpage>373</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1017/S0033583510000156</pub-id>
<?supplied-pmid 20731893?><pub-id pub-id-type="pmid">20731893</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>D. A.</given-names></name><name><surname>Oliver</surname><given-names>B. G.</given-names></name><name><surname>Graser</surname><given-names>Y.</given-names></name><name><surname>Goldberg</surname><given-names>J. M.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Comparative genome analysis of <italic>Trichophyton rubrum</italic> and related dermatophytes reveals candidate genes involved in infection.</article-title>
<source><italic>mBio</italic></source>
<volume>3</volume>:<issue>e00259-12</issue>. <pub-id pub-id-type="doi">10.1128/mBio.00259-12</pub-id>
<?supplied-pmid 22951933?><pub-id pub-id-type="pmid">22951933</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><name><surname>Jacob</surname><given-names>T. R.</given-names></name><name><surname>Sanches</surname><given-names>P. R.</given-names></name><name><surname>Peres</surname><given-names>N. T.</given-names></name><name><surname>Lang</surname><given-names>E. A.</given-names></name><name><surname>Martins</surname><given-names>M. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Heat shock proteins in dermatophytes: current advances and perspectives.</article-title>
<source><italic>Curr. Genomics</italic></source>
<volume>17</volume>
<fpage>99</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.2174/1389202917666151116212437</pub-id>
<?supplied-pmid 27226766?><pub-id pub-id-type="pmid">27226766</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><name><surname>Peres</surname><given-names>N. T.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Pathogenesis of dermatophytosis: sensing the host tissue.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>182</volume>
<fpage>215</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-016-0057-9</pub-id>
<?supplied-pmid 27590362?><pub-id pub-id-type="pmid">27590362</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><name><surname>Peres</surname><given-names>N. T. A.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Antifungal resistance mechanisms in dermatophytes.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>166</volume>
<fpage>369</fpage>&#x02013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-008-9110-7</pub-id>
<?supplied-pmid 18478356?><pub-id pub-id-type="pmid">18478356</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>M. P.</given-names></name><name><surname>Franceschini</surname><given-names>A. C. C.</given-names></name><name><surname>Jacob</surname><given-names>T. R.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>65</volume>
<fpage>605</fpage>&#x02013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000268</pub-id>
<?supplied-pmid 27121717?><pub-id pub-id-type="pmid">27121717</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbaveng</surname><given-names>A. T.</given-names></name><name><surname>Ngameni</surname><given-names>B.</given-names></name><name><surname>Kuete</surname><given-names>V.</given-names></name><name><surname>Simo</surname><given-names>I. K.</given-names></name><name><surname>Ambassa</surname><given-names>P.</given-names></name><name><surname>Roy</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Antimicrobial activity of the crude extracts and five flavonoids from the twigs of <italic>Dorstenia barteri</italic> (Moraceae).</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>116</volume>
<fpage>483</fpage>&#x02013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2007.12.017</pub-id>
<?supplied-pmid 18280679?><pub-id pub-id-type="pmid">18280679</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>M. W.</given-names></name><name><surname>Kontoyiannis</surname><given-names>D. P.</given-names></name><name><surname>Cornely</surname><given-names>O. A.</given-names></name><name><surname>Perfect</surname><given-names>J. R.</given-names></name><name><surname>Walsh</surname><given-names>T. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Novel agents and drug targets to meet the challenges of resistant fungi.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>216</volume>
<fpage>S474</fpage>&#x02013;<lpage>S483</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix130</pub-id>
<?supplied-pmid 28911042?><pub-id pub-id-type="pmid">28911042</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medeiros</surname><given-names>M. R.</given-names></name><name><surname>Prado</surname><given-names>L. A.</given-names></name><name><surname>Fernandes</surname><given-names>V. C.</given-names></name><name><surname>Figueiredo</surname><given-names>S. S.</given-names></name><name><surname>Coppede</surname><given-names>J.</given-names></name><name><surname>Martins</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Antimicrobial activities of indole alkaloids from <italic>Tabernaemontana catharinensis</italic>.</article-title>
<source><italic>Nat. Prod. Commun.</italic></source>
<volume>6</volume>
<fpage>193</fpage>&#x02013;<lpage>196</lpage>. <?supplied-pmid 21425672?><pub-id pub-id-type="pmid">21425672</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>N. S.</given-names></name><name><surname>Bitencourt</surname><given-names>T. A.</given-names></name><name><surname>Sanches</surname><given-names>P. R.</given-names></name><name><surname>Silva-Rocha</surname><given-names>R.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Transcriptome-wide survey of gene expression changes and alternative splicing in <italic>Trichophyton rubrum</italic> in response to undecanoic acid.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>2520</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-20738-x</pub-id>
<?supplied-pmid 29410524?><pub-id pub-id-type="pmid">29410524</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuyama</surname><given-names>J.</given-names></name><name><surname>Nomura</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>E.</given-names></name><name><surname>Nishikawa</surname><given-names>H.</given-names></name><name><surname>Kaeriyama</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> antifungal activities of T-2307, a novel arylamidine.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>52</volume>
<fpage>1318</fpage>&#x02013;<lpage>1324</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01159-07</pub-id>
<?supplied-pmid 18227186?><pub-id pub-id-type="pmid">18227186</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M.</given-names></name><name><surname>Horii</surname><given-names>T.</given-names></name><name><surname>Hata</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>N. A.</given-names></name><name><surname>Nakamoto</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title><italic>In vitro</italic> activity of E1210, a novel antifungal, against clinically important yeasts and molds.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>55</volume>
<fpage>4652</fpage>&#x02013;<lpage>4658</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00291-11</pub-id>
<?supplied-pmid 21825291?><pub-id pub-id-type="pmid">21825291</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monod</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Secreted proteases from dermatophytes.</article-title>
<source><italic>Mycopathologia</italic></source>
<volume>166</volume>
<fpage>285</fpage>&#x02013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-008-9105-4</pub-id>
<?supplied-pmid 18478360?><pub-id pub-id-type="pmid">18478360</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mor</surname><given-names>V.</given-names></name><name><surname>Rella</surname><given-names>A.</given-names></name><name><surname>Farnoud</surname><given-names>A. M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Munshi</surname><given-names>M.</given-names></name><name><surname>Bryan</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids.</article-title>
<source><italic>mBio</italic></source>
<volume>6</volume>:<issue>e00647-15</issue>. <pub-id pub-id-type="doi">10.1128/mBio.00647-15</pub-id>
<?supplied-pmid 26106079?><pub-id pub-id-type="pmid">26106079</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morio</surname><given-names>F.</given-names></name><name><surname>Loge</surname><given-names>C.</given-names></name><name><surname>Besse</surname><given-names>B.</given-names></name><name><surname>Hennequin</surname><given-names>C.</given-names></name><name><surname>Le Pape</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Screening for amino acid substitutions in the <italic>Candida albicans</italic> Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.</article-title>
<source><italic>Diagn. Microbiol. Infect. Dis.</italic></source>
<volume>66</volume>
<fpage>373</fpage>&#x02013;<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2009.11.006</pub-id>
<?supplied-pmid 20226328?><pub-id pub-id-type="pmid">20226328</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morteza-Semnani</surname><given-names>K.</given-names></name><name><surname>Amin</surname><given-names>G.</given-names></name><name><surname>Shidfar</surname><given-names>M. R.</given-names></name><name><surname>Hadizadeh</surname><given-names>H.</given-names></name><name><surname>Shafiee</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Antifungal activity of the methanolic extract and alkaloids of <italic>Glaucium oxylobum</italic>.</article-title>
<source><italic>Fitoterapia</italic></source>
<volume>74</volume>
<fpage>493</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0367-326X(03)00113-8</pub-id>
<?supplied-pmid 12837370?><pub-id pub-id-type="pmid">12837370</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narender</surname><given-names>T.</given-names></name><name><surname>Reddy</surname><given-names>K. P.</given-names></name></person-group> (<year>2007</year>). <article-title>A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate.</article-title>
<source><italic>Tetrahedron Lett.</italic></source>
<volume>48</volume>
<fpage>3177</fpage>&#x02013;<lpage>3180</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2007.03.054</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negri</surname><given-names>M.</given-names></name><name><surname>Salci</surname><given-names>T. P.</given-names></name><name><surname>Shinobu-Mesquita</surname><given-names>C. S.</given-names></name><name><surname>Capoci</surname><given-names>I. R.</given-names></name><name><surname>Svidzinski</surname><given-names>T. I.</given-names></name><name><surname>Kioshima</surname><given-names>E. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Early state research on antifungal natural products.</article-title>
<source><italic>Molecules</italic></source>
<volume>19</volume>
<fpage>2925</fpage>&#x02013;<lpage>2956</lpage>. <pub-id pub-id-type="doi">10.3390/molecules19032925</pub-id>
<?supplied-pmid 24609016?><pub-id pub-id-type="pmid">24609016</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>Y.</given-names></name><name><surname>Mitsuyama</surname><given-names>J.</given-names></name><name><surname>Tashiro</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>A.</given-names></name><name><surname>Takazono</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> antifungal activities of T-2307, a novel arylamidine, against <italic>Cryptococcus gattii</italic>: an emerging fungal pathogen.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>72</volume>
<fpage>1709</fpage>&#x02013;<lpage>1713</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkx020</pub-id>
<?supplied-pmid 28201509?><pub-id pub-id-type="pmid">28201509</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>K.</given-names></name><name><surname>Fukazawa</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Uehara</surname><given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Nek11, a new member of the NIMA family of kinases, involved in DNA replication and genotoxic stress responses.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>277</volume>
<fpage>39655</fpage>&#x02013;<lpage>39665</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M204599200</pub-id>
<?supplied-pmid 12154088?><pub-id pub-id-type="pmid">12154088</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowakowska</surname><given-names>Z.</given-names></name></person-group> (<year>2007</year>). <article-title>A review of anti-infective and anti-inflammatory chalcones.</article-title>
<source><italic>Eur. J. Med. Chem.</italic></source>
<volume>42</volume>
<fpage>125</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2006.09.019</pub-id>
<?supplied-pmid 17112640?><pub-id pub-id-type="pmid">17112640</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowosielski</surname><given-names>M.</given-names></name><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Wyrwicz</surname><given-names>L. S.</given-names></name><name><surname>Stepniak</surname><given-names>P.</given-names></name><name><surname>Plewczynski</surname><given-names>D. M.</given-names></name><name><surname>Lazniewski</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Detailed mechanism of squalene epoxidase inhibition by terbinafine.</article-title>
<source><italic>J. Chem. Inf. Model.</italic></source>
<volume>51</volume>
<fpage>455</fpage>&#x02013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1021/ci100403b</pub-id>
<?supplied-pmid 21229992?><pub-id pub-id-type="pmid">21229992</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>J. D.</given-names></name><name><surname>Sibley</surname><given-names>G. E. M.</given-names></name><name><surname>Beckmann</surname><given-names>N.</given-names></name><name><surname>Dobb</surname><given-names>K. S.</given-names></name><name><surname>Slater</surname><given-names>M. J.</given-names></name><name><surname>Mcentee</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>113</volume>
<fpage>12809</fpage>&#x02013;<lpage>12814</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1608304113</pub-id>
<?supplied-pmid 27791100?><pub-id pub-id-type="pmid">27791100</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne</surname><given-names>C. S.</given-names></name><name><surname>Leitner</surname><given-names>I.</given-names></name><name><surname>Favre</surname><given-names>B.</given-names></name><name><surname>Ryder</surname><given-names>N. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Amino acid substitution in <italic>Trichophyton rubrum</italic> squalene epoxidase associated with resistance to terbinafine.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>49</volume>
<fpage>2840</fpage>&#x02013;<lpage>2844</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.49.7.2840-2844.2005</pub-id>
<?supplied-pmid 15980358?><pub-id pub-id-type="pmid">15980358</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osmani</surname><given-names>S. A.</given-names></name><name><surname>Pu</surname><given-names>R. T.</given-names></name><name><surname>Morris</surname><given-names>N. R.</given-names></name></person-group> (<year>1988</year>). <article-title>Mitotic induction and maintenance by overexpression of a G2-specific gene that encodes a potential protein kinase.</article-title>
<source><italic>Cell</italic></source>
<volume>53</volume>
<fpage>237</fpage>&#x02013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(88)90385-6</pub-id>
<?supplied-pmid 3359487?><pub-id pub-id-type="pmid">3359487</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai&#x000e3;o</surname><given-names>F. G.</given-names></name><name><surname>Segato</surname><given-names>F.</given-names></name><name><surname>Cursino-Santos</surname><given-names>J. R.</given-names></name><name><surname>Peres</surname><given-names>N. T.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Analysis of <italic>Trichophyton rubrum</italic> gene expression in response to cytotoxic drugs.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>271</volume>
<fpage>180</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00710.x</pub-id>
<?supplied-pmid 17425668?><pub-id pub-id-type="pmid">17425668</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>L. R.</given-names></name><name><surname>Komander</surname><given-names>D.</given-names></name><name><surname>Alessi</surname><given-names>D. R.</given-names></name></person-group> (<year>2010</year>). <article-title>The nuts and bolts of AGC protein kinases.</article-title>
<source><italic>Nat. Rev. Mol. Cell Biol.</italic></source>
<volume>11</volume>
<fpage>9</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2822</pub-id>
<?supplied-pmid 20027184?><pub-id pub-id-type="pmid">20027184</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peman</surname><given-names>J.</given-names></name><name><surname>Canton</surname><given-names>E.</given-names></name><name><surname>Espinel-Ingroff</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Antifungal drug resistance mechanisms.</article-title>
<source><italic>Expert Rev. Anti Infect. Ther.</italic></source>
<volume>7</volume>
<fpage>453</fpage>&#x02013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1586/eri.09.18</pub-id>
<?supplied-pmid 19400764?><pub-id pub-id-type="pmid">19400764</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peres</surname><given-names>N. T. A.</given-names></name><name><surname>Maranh&#x000e3;o</surname><given-names>F. C.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2010a</year>). <article-title>Dermatophytes: host-pathogen interaction and antifungal resistance.</article-title>
<source><italic>An. Bras. Dermatol.</italic></source>
<volume>85</volume>
<fpage>657</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="pmid">21152790</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peres</surname><given-names>N. T. A.</given-names></name><name><surname>Sanches</surname><given-names>P. R.</given-names></name><name><surname>Falc&#x000e3;o</surname><given-names>J. P.</given-names></name><name><surname>Silveira</surname><given-names>H. C. S.</given-names></name><name><surname>Pai&#x000e3;o</surname><given-names>F. G.</given-names></name><name><surname>Maranh&#x000e3;o</surname><given-names>F. C. A.</given-names></name><etal/></person-group> (<year>2010b</year>). <article-title>Transcriptional profiling reveals the expression of novel genes in response to various stimuli in the human dermatophyte <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>10</volume>:<issue>39</issue>. <pub-id pub-id-type="doi">10.1186/1471-2180-10-39</pub-id>
<?supplied-pmid 20144196?><pub-id pub-id-type="pmid">20144196</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlin</surname><given-names>D. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of echinocandin antifungal drug resistance.</article-title>
<source><italic>Ann. N. Y. Acad. Sci.</italic></source>
<volume>1354</volume>
<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1111/nyas.12831</pub-id>
<?supplied-pmid 26190298?><pub-id pub-id-type="pmid">26190298</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persinoti</surname><given-names>G. F.</given-names></name><name><surname>Peres</surname><given-names>N. T. A.</given-names></name><name><surname>Jacob</surname><given-names>T. R.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Vencio</surname><given-names>R. Z.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2014</year>). <article-title>RNA-seq <italic>Trichophyton rubrum</italic> transcriptome analysis in response to the cytotoxic drug acriflavine.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>15</volume>:<issue>S1</issue>. <pub-id pub-id-type="doi">10.1186/1471-2164-15-S7-S1</pub-id>
<?supplied-pmid 25573029?><pub-id pub-id-type="pmid">25573029</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>M. A.</given-names></name><name><surname>Messer</surname><given-names>S. A.</given-names></name><name><surname>Georgopapadakou</surname><given-names>N.</given-names></name><name><surname>Martell</surname><given-names>L. A.</given-names></name><name><surname>Besterman</surname><given-names>J. M.</given-names></name><name><surname>Diekema</surname><given-names>D. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>47</volume>
<fpage>3797</fpage>&#x02013;<lpage>3804</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00618-09</pub-id>
<?supplied-pmid 19794038?><pub-id pub-id-type="pmid">19794038</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>M. A.</given-names></name><name><surname>Messer</surname><given-names>S. A.</given-names></name><name><surname>Rhomberg</surname><given-names>P. R.</given-names></name><name><surname>Jones</surname><given-names>R. N.</given-names></name><name><surname>Castanheira</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against <italic>Candida</italic> and <italic>Aspergillus</italic> spp., including echinocandin- and azole-resistant isolates.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>71</volume>
<fpage>2868</fpage>&#x02013;<lpage>2873</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkw214</pub-id>
<?supplied-pmid 27287236?><pub-id pub-id-type="pmid">27287236</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pianalto</surname><given-names>K. M.</given-names></name><name><surname>Alspaugh</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>New horizons in antifungal therapy.</article-title>
<source><italic>J. Fungi</italic></source>
<volume>2</volume>:<issue>E26</issue>. <pub-id pub-id-type="doi">10.3390/jof2040026</pub-id>
<?supplied-pmid 29376943?><pub-id pub-id-type="pmid">29376943</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portillo</surname><given-names>A.</given-names></name><name><surname>Vila</surname><given-names>R.</given-names></name><name><surname>Freixa</surname><given-names>B.</given-names></name><name><surname>Ferro</surname><given-names>E.</given-names></name><name><surname>Parella</surname><given-names>T.</given-names></name><name><surname>Casanova</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Antifungal sesquiterpene from the root of <italic>Vernonanthura tweedieana</italic>.</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>97</volume>
<fpage>49</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2004.09.052</pub-id>
<?supplied-pmid 15652274?><pub-id pub-id-type="pmid">15652274</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putman</surname><given-names>M.</given-names></name><name><surname>Van Veen</surname><given-names>H. W.</given-names></name><name><surname>Konings</surname><given-names>W. N.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular properties of bacterial multidrug transporters.</article-title>
<source><italic>Microbiol. Mol. Biol. Rev.</italic></source>
<volume>64</volume>
<fpage>672</fpage>&#x02013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.64.4.672-693.2000</pub-id><pub-id pub-id-type="pmid">11104814</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>J.</given-names></name><name><surname>Cartuche</surname><given-names>L.</given-names></name><name><surname>Morocho</surname><given-names>V.</given-names></name><name><surname>Aguilar</surname><given-names>S.</given-names></name><name><surname>Malagon</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>Antifungal activity of raw extract and flavanons isolated from <italic>Piper ecuadorense</italic> from Ecuador.</article-title>
<source><italic>Rev. Bras. Farmacogn.</italic></source>
<volume>23</volume>
<fpage>370</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1590/S0102-695X2013005000012</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>N.</given-names></name><name><surname>Caplan</surname><given-names>T.</given-names></name><name><surname>Cowen</surname><given-names>L. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular evolution of antifungal drug resistance.</article-title>
<source><italic>Annu. Rev. Microbiol.</italic></source>
<volume>71</volume>
<fpage>753</fpage>&#x02013;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-micro-030117-020345</pub-id>
<?supplied-pmid 28886681?><pub-id pub-id-type="pmid">28886681</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>E. M. F.</given-names></name><name><surname>Gardiner</surname><given-names>R. E.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name><name><surname>Perlin</surname><given-names>D. S.</given-names></name></person-group> (<year>2006</year>). <article-title>A Phe389Leu substitution in ErgA confers terbinafine resistance in <italic>Aspergillus fumigatus</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>50</volume>
<fpage>2533</fpage>&#x02013;<lpage>2536</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00187-06</pub-id>
<?supplied-pmid 16801438?><pub-id pub-id-type="pmid">16801438</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooker</surname><given-names>S.</given-names></name><name><surname>Guillemaud</surname><given-names>T.</given-names></name><name><surname>Berge</surname><given-names>J.</given-names></name><name><surname>Pasteur</surname><given-names>N.</given-names></name><name><surname>Raymond</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Coamplification of esterase A and B genes as a single unit in <italic>Culex pipiens</italic> mosquitoes.</article-title>
<source><italic>Heredity</italic></source>
<volume>77</volume>
<fpage>555</fpage>&#x02013;<lpage>561</lpage>. <?supplied-pmid 8939022?><pub-id pub-id-type="pmid">8939022</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagatova</surname><given-names>A. A.</given-names></name><name><surname>Keniya</surname><given-names>M. V.</given-names></name><name><surname>Wilson</surname><given-names>R. K.</given-names></name><name><surname>Sabherwal</surname><given-names>M.</given-names></name><name><surname>Tyndall</surname><given-names>J. D. A.</given-names></name><name><surname>Monk</surname><given-names>B. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14 alpha-demethylase.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>26213</issue>. <pub-id pub-id-type="doi">10.1038/srep26213</pub-id>
<?supplied-pmid 27188873?><pub-id pub-id-type="pmid">27188873</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgueiro</surname><given-names>L. R.</given-names></name><name><surname>Pinto</surname><given-names>E.</given-names></name><name><surname>Goncalves</surname><given-names>M. J.</given-names></name><name><surname>Pina-Vaz</surname><given-names>C.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Rodrigues</surname><given-names>A. G.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Chemical composition and antifungal activity of the essential oil of <italic>Thymbra capitata</italic>.</article-title>
<source><italic>Planta Med.</italic></source>
<volume>70</volume>
<fpage>572</fpage>&#x02013;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1055/s-2004-827162</pub-id>
<?supplied-pmid 15229809?><pub-id pub-id-type="pmid">15229809</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanglard</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Emerging threats in antifungal-resistant fungal pathogens.</article-title>
<source><italic>Front. Med.</italic></source>
<volume>3</volume>:<issue>11</issue>. <pub-id pub-id-type="doi">10.3389/fmed.2016.00011</pub-id>
<?supplied-pmid 27014694?><pub-id pub-id-type="pmid">27014694</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanglard</surname><given-names>D.</given-names></name><name><surname>Coste</surname><given-names>A.</given-names></name><name><surname>Ferrari</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.</article-title>
<source><italic>FEMS Yeast Res.</italic></source>
<volume>9</volume>
<fpage>1029</fpage>&#x02013;<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1111/j.1567-1364.2009.00578.x</pub-id>
<?supplied-pmid 19799636?><pub-id pub-id-type="pmid">19799636</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>H. L.</given-names></name><name><surname>Lang</surname><given-names>E. A. S.</given-names></name><name><surname>Segato</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Terbinafine resistance conferred by multiple copies of the salicylate 1-monooxygenase gene in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>56</volume>
<fpage>378</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1093/mmy/myx044</pub-id>
<?supplied-pmid 28582544?><pub-id pub-id-type="pmid">28582544</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>M. A.</given-names></name><name><surname>Jimenez</surname><given-names>A.</given-names></name><name><surname>Revuelta</surname><given-names>J. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular characterization of <italic>FMN1</italic>, the structural gene for the monofunctional flavokinase of <italic>Saccharomyces cerevisiae</italic>.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>275</volume>
<fpage>28618</fpage>&#x02013;<lpage>28624</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M004621200</pub-id>
<?supplied-pmid 10887197?><pub-id pub-id-type="pmid">10887197</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schell</surname><given-names>W. A.</given-names></name><name><surname>Jones</surname><given-names>A. M.</given-names></name><name><surname>Borroto-Esoda</surname><given-names>K.</given-names></name><name><surname>Alexander</surname><given-names>B. D.</given-names></name></person-group> (<year>2017a</year>). <article-title>Antifungal activity of SCY-078 and standard antifungal agents against 178 clinical iisolates of resistant and susceptible <italic>Candida</italic> species.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e01102</issue>-17. <pub-id pub-id-type="doi">10.1128/AAC.01102-17</pub-id>
<?supplied-pmid 28827419?><pub-id pub-id-type="pmid">28827419</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schell</surname><given-names>W. A.</given-names></name><name><surname>Jones</surname><given-names>A. M.</given-names></name><name><surname>Garvey</surname><given-names>E. P.</given-names></name><name><surname>Hoekstra</surname><given-names>W. J.</given-names></name><name><surname>Schotzinger</surname><given-names>R. J.</given-names></name><name><surname>Alexander</surname><given-names>B. D.</given-names></name></person-group> (<year>2017b</year>). <article-title>Fungal CYP51 inhibitors VT-1161 and VT-1129 exhibit strong <italic>in vitro</italic> activity against <italic>Candida glabrata</italic> and <italic>C. krusei</italic> isolates clinically resistant to azole and echinocandin antifungal compounds.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e01817-16</issue>. <pub-id pub-id-type="doi">10.1128/AAC.01817-16</pub-id>
<?supplied-pmid 27956419?><pub-id pub-id-type="pmid">27956419</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schopf</surname><given-names>F. H.</given-names></name><name><surname>Biebl</surname><given-names>M. M.</given-names></name><name><surname>Buchner</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>The Hsp90 chaperone machinery.</article-title>
<source><italic>Nat. Rev. Mol. Cell Biol.</italic></source>
<volume>18</volume>
<fpage>345</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.20</pub-id>
<?supplied-pmid 28429788?><pub-id pub-id-type="pmid">28429788</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segato</surname><given-names>F.</given-names></name><name><surname>Nozawa</surname><given-names>S. R.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Martinez-Rossi</surname><given-names>N. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Over-expression of genes coding for proline oxidase, riboflavin kinase, cytochrome c oxidase and an MFS transporter induced by acriflavin in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Med. Mycol.</italic></source>
<volume>46</volume>
<fpage>135</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1080/13693780701742381</pub-id>
<?supplied-pmid 18324492?><pub-id pub-id-type="pmid">18324492</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selmecki</surname><given-names>A.</given-names></name><name><surname>Forche</surname><given-names>A.</given-names></name><name><surname>Berman</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Genomic plasticity of the human fungal pathogen <italic>Candida albicans</italic>.</article-title>
<source><italic>Eukaryot. Cell</italic></source>
<volume>9</volume>
<fpage>991</fpage>&#x02013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1128/EC.00060-10</pub-id>
<?supplied-pmid 20495058?><pub-id pub-id-type="pmid">20495058</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Manoharlal</surname><given-names>R.</given-names></name><name><surname>Shukla</surname><given-names>S.</given-names></name><name><surname>Puri</surname><given-names>N.</given-names></name><name><surname>Prasad</surname><given-names>T.</given-names></name><name><surname>Ambudkar</surname><given-names>S. V.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>53</volume>
<fpage>3256</fpage>&#x02013;<lpage>3265</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01497-08</pub-id>
<?supplied-pmid 19470507?><pub-id pub-id-type="pmid">19470507</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Prasad</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in <italic>Candida albicans</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>55</volume>
<fpage>4834</fpage>&#x02013;<lpage>4843</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00344-11</pub-id>
<?supplied-pmid 21768514?><pub-id pub-id-type="pmid">21768514</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shubitz</surname><given-names>L. F.</given-names></name><name><surname>Trinh</surname><given-names>H. T.</given-names></name><name><surname>Perrill</surname><given-names>R. H.</given-names></name><name><surname>Thompson</surname><given-names>C. M.</given-names></name><name><surname>Hanan</surname><given-names>N. J.</given-names></name><name><surname>Galgiani</surname><given-names>J. N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>209</volume>
<fpage>1949</fpage>&#x02013;<lpage>1954</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu029</pub-id>
<?supplied-pmid 24421256?><pub-id pub-id-type="pmid">24421256</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Joshi</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Treatment of dermatophytosis by a new antifungal agent &#x02019;apigenin&#x02019;.</article-title>
<source><italic>Mycoses</italic></source>
<volume>57</volume>
<fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1111/myc.12188</pub-id>
<?supplied-pmid 24708558?><pub-id pub-id-type="pmid">24708558</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S. B.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Shafiee</surname><given-names>A.</given-names></name><name><surname>Card</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h.</article-title>
<source><italic>ACS Med. Chem. Lett.</italic></source>
<volume>3</volume>
<fpage>814</fpage>&#x02013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1021/ml300173e</pub-id>
<?supplied-pmid 24900384?><pub-id pub-id-type="pmid">24900384</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S. D.</given-names></name><name><surname>Robbins</surname><given-names>N.</given-names></name><name><surname>Zaas</surname><given-names>A. K.</given-names></name><name><surname>Schell</surname><given-names>W. A.</given-names></name><name><surname>Perfect</surname><given-names>J. R.</given-names></name><name><surname>Cowen</surname><given-names>L. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Hsp90 governs echinocandin resistance in the pathogenic yeast <italic>Candida albicans</italic> via calcineurin.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>5</volume>:<issue>e1000532</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000532</pub-id>
<?supplied-pmid 19649312?><pub-id pub-id-type="pmid">19649312</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sionov</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Chang</surname><given-names>Y. C.</given-names></name><name><surname>Kwon-Chung</surname><given-names>K. J.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Cryptococcus neoformans</italic> overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>6</volume>:<issue>e1000848</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000848</pub-id>
<?supplied-pmid 20368972?><pub-id pub-id-type="pmid">20368972</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokovic</surname><given-names>M.</given-names></name><name><surname>Glamoclija</surname><given-names>J.</given-names></name><name><surname>Ciric</surname><given-names>A.</given-names></name><name><surname>Kataranovski</surname><given-names>D.</given-names></name><name><surname>Marin</surname><given-names>P. D.</given-names></name><name><surname>Vukojevic</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Antifungal activity of the essential oil of <italic>Thymus vulgaris</italic> L. and thymol on experimentally induced dermatomycoses.</article-title>
<source><italic>Drug Dev. Ind. Pharm.</italic></source>
<volume>34</volume>
<fpage>1388</fpage>&#x02013;<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1080/03639040802130053</pub-id>
<?supplied-pmid 18651285?><pub-id pub-id-type="pmid">18651285</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwunnakorn</surname><given-names>S.</given-names></name><name><surname>Wakabayashi</surname><given-names>H.</given-names></name><name><surname>Kordalewska</surname><given-names>M.</given-names></name><name><surname>Perlin</surname><given-names>D. S.</given-names></name><name><surname>Rustchenko</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>FKS2</italic> and <italic>FKS3</italic> genes of opportunistic human pathogen <italic>Candida albicans</italic> influence echinocandin susceptibility.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>62</volume>:<issue>e02299</issue>-17. <pub-id pub-id-type="doi">10.1128/AAC.02299-17</pub-id>
<?supplied-pmid 29358288?><pub-id pub-id-type="pmid">29358288</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svetaz</surname><given-names>L.</given-names></name><name><surname>Aguero</surname><given-names>M. B.</given-names></name><name><surname>Alvarez</surname><given-names>S.</given-names></name><name><surname>Luna</surname><given-names>L.</given-names></name><name><surname>Feresin</surname><given-names>G.</given-names></name><name><surname>Derita</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Antifungal activity of <italic>Zuccagnia punctata</italic> Cav.: evidence for the mechanism of action.</article-title>
<source><italic>Planta Med.</italic></source>
<volume>73</volume>
<fpage>1074</fpage>&#x02013;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-981561</pub-id>
<?supplied-pmid 17628836?><pub-id pub-id-type="pmid">17628836</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taipale</surname><given-names>M.</given-names></name><name><surname>Jarosz</surname><given-names>D. F.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Hsp90 at the hub of protein homeostasis: emerging mechanistic insights.</article-title>
<source><italic>Nat. Rev. Mol. Cell Biol.</italic></source>
<volume>11</volume>
<fpage>515</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2918</pub-id>
<?supplied-pmid 20531426?><pub-id pub-id-type="pmid">20531426</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamayo</surname><given-names>D.</given-names></name><name><surname>Munoz</surname><given-names>J. F.</given-names></name><name><surname>Torres</surname><given-names>I.</given-names></name><name><surname>Almeida</surname><given-names>A. J.</given-names></name><name><surname>Restrepo</surname><given-names>A.</given-names></name><name><surname>Mcewen</surname><given-names>J. G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Involvement of the 90 kDa heat shock protein during adaptation of <italic>Paracoccidioides brasiliensis</italic> to different environmental conditions.</article-title>
<source><italic>Fungal Genet. Biol.</italic></source>
<volume>51</volume>
<fpage>34</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.fgb.2012.11.005</pub-id>
<?supplied-pmid 23207691?><pub-id pub-id-type="pmid">23207691</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teodoro</surname><given-names>G. R.</given-names></name><name><surname>Ellepola</surname><given-names>K.</given-names></name><name><surname>Seneviratne</surname><given-names>C. J.</given-names></name><name><surname>Koga-Ito</surname><given-names>C. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Potential use of phenolic acids as anti-<italic>Candida</italic> agents: a review.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>1420</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.01420</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>S.</given-names></name><name><surname>Thakur</surname><given-names>R.</given-names></name><name><surname>Shankar</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of heat-shock proteins in cellular function and in the biology of fungi.</article-title>
<source><italic>Biotechnol. Res. Int.</italic></source>
<volume>2015</volume>:<issue>132635</issue>. <pub-id pub-id-type="doi">10.1155/2015/132635</pub-id>
<?supplied-pmid 26881084?><pub-id pub-id-type="pmid">26881084</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomoike</surname><given-names>F.</given-names></name><name><surname>Nakagawa</surname><given-names>N.</given-names></name><name><surname>Fukui</surname><given-names>K.</given-names></name><name><surname>Yano</surname><given-names>T.</given-names></name><name><surname>Kuramitsu</surname><given-names>S.</given-names></name><name><surname>Masui</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Indispensable residue for uridine binding in the uridine-cytidine kinase family.</article-title>
<source><italic>Biochem. Biophys. Rep.</italic></source>
<volume>11</volume>
<fpage>93</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrep.2017.07.002</pub-id>
<?supplied-pmid 28955773?><pub-id pub-id-type="pmid">28955773</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Natural product origins of Hsp90 inhibitors.</article-title>
<source><italic>Curr. Cancer Drug Targets</italic></source>
<volume>3</volume>
<fpage>325</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.2174/1568009033481796</pub-id>
<?supplied-pmid 14529384?><pub-id pub-id-type="pmid">14529384</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadler</surname><given-names>C.</given-names></name><name><surname>Cronan</surname><given-names>J. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Dephospho-CoA kinase provides a rapid and sensitive radiochemical assay for coenzyme A and its thioesters.</article-title>
<source><italic>Anal. Biochem.</italic></source>
<volume>368</volume>
<fpage>17</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2007.05.031</pub-id>
<?supplied-pmid 17603993?><pub-id pub-id-type="pmid">17603993</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Dong</surname><given-names>H. H.</given-names></name><name><surname>Zhao</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><name><surname>Jiang</surname><given-names>Y. Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The synthesis and synergistic antifungal effects of chalcones against drug resistant <italic>Candida albicans</italic>.</article-title>
<source><italic>Bioorg. Med. Chem. Lett.</italic></source>
<volume>26</volume>
<fpage>3098</fpage>&#x02013;<lpage>3102</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2016.05.013</pub-id>
<?supplied-pmid 27210436?><pub-id pub-id-type="pmid">27210436</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrilow</surname><given-names>A. G. S.</given-names></name><name><surname>Hull</surname><given-names>C. M.</given-names></name><name><surname>Parker</surname><given-names>J. E.</given-names></name><name><surname>Garvey</surname><given-names>E. P.</given-names></name><name><surname>Hoekstra</surname><given-names>W. J.</given-names></name><name><surname>Moore</surname><given-names>W. R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The clinical candidate VT-1161 is a highly potent inhibitor of <italic>Candida albicans</italic> CYP51 but fails to bind the human enzyme.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>58</volume>
<fpage>7121</fpage>&#x02013;<lpage>7127</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03707-14</pub-id>
<?supplied-pmid 25224009?><pub-id pub-id-type="pmid">25224009</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widmann</surname><given-names>C.</given-names></name><name><surname>Gibson</surname><given-names>S.</given-names></name><name><surname>Jarpe</surname><given-names>M. B.</given-names></name><name><surname>Johnson</surname><given-names>G. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.</article-title>
<source><italic>Physiol. Rev.</italic></source>
<volume>79</volume>
<fpage>143</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.1999.79.1.143</pub-id>
<?supplied-pmid 9922370?><pub-id pub-id-type="pmid">9922370</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederhold</surname><given-names>N. P.</given-names></name><name><surname>Patterson</surname><given-names>H. P.</given-names></name><name><surname>Tran</surname><given-names>B. H.</given-names></name><name><surname>Yates</surname><given-names>C. M.</given-names></name><name><surname>Schotzinger</surname><given-names>R. J.</given-names></name><name><surname>Garvey</surname><given-names>E. P.</given-names></name></person-group> (<year>2018a</year>). <article-title>Fungal-specific Cyp51 inhibitor VT-1598 demonstrates <italic>in vitro</italic> activity against <italic>Candida</italic> and <italic>Cryptococcus</italic> species, endemic fungi, including <italic>Coccidioides</italic> species, <italic>Aspergillus</italic> species and <italic>Rhizopus arrhizus</italic>.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>73</volume>
<fpage>404</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkx410</pub-id>
<?supplied-pmid 29190379?><pub-id pub-id-type="pmid">29190379</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederhold</surname><given-names>N. P.</given-names></name><name><surname>Shubitz</surname><given-names>L. F.</given-names></name><name><surname>Najvar</surname><given-names>L. K.</given-names></name><name><surname>Jaramillo</surname><given-names>R.</given-names></name><name><surname>Olivo</surname><given-names>M.</given-names></name><name><surname>Catano</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2018b</year>). <article-title>The novel fungal Cyp51 inhibitor VT-1598 is efficacious in experimental models of central nervous system coccidioidomycosis caused by <italic>Coccidioides posadasii</italic> and <italic>Coccidioides immitis</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>62</volume>:<issue>e02258</issue>-17. <pub-id pub-id-type="doi">10.1128/AAC.02258-17</pub-id>
<?supplied-pmid 29437615?><pub-id pub-id-type="pmid">29437615</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodfolk</surname><given-names>J. A.</given-names></name><name><surname>Platts-Mills</surname><given-names>T. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Diversity of the human allergen-specific T cell repertoire associated with distinct skin test reactions: delayed-type hypersensitivity-associated major epitopes induce Th1- and Th2-dominated responses.</article-title>
<source><italic>J. Immunol.</italic></source>
<volume>167</volume>
<fpage>5412</fpage>&#x02013;<lpage>5419</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.167.9.5412</pub-id>
<?supplied-pmid 11673560?><pub-id pub-id-type="pmid">11673560</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>J. M.</given-names></name><name><surname>Yuan</surname><given-names>D. X.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Miao</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>Tracing the structural evolution of eukaryotic ATP binding cassette transporter superfamily.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>5</volume>:<issue>16724</issue>. <pub-id pub-id-type="doi">10.1038/srep16724</pub-id>
<?supplied-pmid 26577702?><pub-id pub-id-type="pmid">26577702</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Alshahni</surname><given-names>M. M.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Yaguchi</surname><given-names>T.</given-names></name><name><surname>Bontems</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Terbinafine resistance of <italic>Trichophyton</italic> clinical isolates caused by specific point mutations in the squalene epoxidase gene.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>61</volume>:<issue>e00115-17</issue>. <pub-id pub-id-type="doi">10.1128/AAC.00115-17</pub-id>
<?supplied-pmid 28416557?><pub-id pub-id-type="pmid">28416557</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yibmantasiri</surname><given-names>P.</given-names></name><name><surname>Bircham</surname><given-names>P. W.</given-names></name><name><surname>Maass</surname><given-names>D. R.</given-names></name><name><surname>Bellows</surname><given-names>D. S.</given-names></name><name><surname>Atkinson</surname><given-names>P. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Networks of genes modulating the pleiotropic drug response in <italic>Saccharomyces cerevisiae</italic>.</article-title>
<source><italic>Mol. Biosyst.</italic></source>
<volume>10</volume>
<fpage>128</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1039/c3mb70351g</pub-id>
<?supplied-pmid 24201294?><pub-id pub-id-type="pmid">24201294</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2007a</year>). <article-title>Global gene expression of <italic>Trichophyton rubrum</italic> in response to PH11B, a novel fatty acid synthase inhibitor.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>103</volume>
<fpage>2346</fpage>&#x02013;<lpage>2352</lpage>. <?supplied-pmid 18045420?><pub-id pub-id-type="pmid">18045420</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2007b</year>). <article-title>Transcriptional profiles of the response to ketoconazole and amphotericin B in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>51</volume>
<fpage>144</fpage>&#x02013;<lpage>153</lpage>. <?supplied-pmid 17060531?><pub-id pub-id-type="pmid">17060531</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Ko</surname><given-names>H. J.</given-names></name><name><surname>Woo</surname><given-names>E. R.</given-names></name><name><surname>Lee</surname><given-names>D. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Fungicidal effect of isoquercitrin via inducing membrane disturbance.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1848</volume>
<fpage>695</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2014.11.019</pub-id>
<?supplied-pmid 25445674?><pub-id pub-id-type="pmid">25445674</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Leng</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>cDNA microarray analysis of the expression profiles of <italic>Trichophyton rubrum</italic> in response to novel synthetic fatty acid synthase inhibitor PHS11A.</article-title>
<source><italic>Fungal Genet. Biol.</italic></source>
<volume>44</volume>
<fpage>1252</fpage>&#x02013;<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1016/j.fgb.2007.03.002</pub-id>
<?supplied-pmid 17442600?><pub-id pub-id-type="pmid">17442600</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>Q.</given-names></name></person-group> (<year>2009</year>). <article-title>Transcriptional profiles of response to terbinafine in <italic>Trichophyton rubrum</italic>.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>82</volume>
<fpage>1123</fpage>&#x02013;<lpage>1130</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-009-1908-9</pub-id>
<?supplied-pmid 19234875?><pub-id pub-id-type="pmid">19234875</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>R.</given-names></name><name><surname>Davey</surname><given-names>M.</given-names></name><name><surname>Hsu</surname><given-names>Y. C.</given-names></name><name><surname>Kaplanek</surname><given-names>P.</given-names></name><name><surname>Tong</surname><given-names>A.</given-names></name><name><surname>Parsons</surname><given-names>A. B.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone.</article-title>
<source><italic>Cell</italic></source>
<volume>120</volume>
<fpage>715</fpage>&#x02013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.024</pub-id>
<?supplied-pmid 15766533?><pub-id pub-id-type="pmid">15766533</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Goncalves</surname><given-names>M. J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Canhoto</surname><given-names>J.</given-names></name><name><surname>Vale-Silva</surname><given-names>L.</given-names></name><name><surname>Silva</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Chemical composition and antifungal activity of the essential oils of <italic>Lavandula viridis</italic> L&#x02019;Her.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>60</volume>
<fpage>612</fpage>&#x02013;<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.027748-0</pub-id>
<?supplied-pmid 21321363?><pub-id pub-id-type="pmid">21321363</pub-id></mixed-citation></ref></ref-list></back></article>